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CHAPTER ONE:  
Introduction to the Clostridium difficile Pathogen and Associated Diseases 
Clostridium difficile (C. diff, Figure 1A) is a Gram-positive, anaerobic pathogen known 
to form spores and give rise to hospital-acquired C. diff-associated diseases (CDAD).1 Often, the 
infection is acquired by patient-to-patient transfer and subsequent ingestion of C. diff spores 
known to survive in the hospital 
setting.2, 3 CDAD is characterized by 
a range of symptoms such as 
excessive diarrhea, colonic 
inflammation, septic shock, 
pseudomembranous colitis (Figure 
1C) and in extreme cases, death.1, 7 
The cycle of CDAD manifestation 
and recurrence is outlined in Figure 
2. Essentially, patient treatment with 
broad-spectrum antibiotics or 
chemotherapeutic agents8 disturbs 
the normal bacterial community 
within the colon, allowing C. diff to 
colonize the gut and cause infection.7 Moreover, several antibiotic-resistant strains are 
continually emerging, only some of which have been characterized.9, 10 These resistant, 
hypervirulent strains, as well as the common production of environmentally-tolerant spores1, 3, 10 
escalate relapse rates in previously treated patients.8 As a consequence of bacterial evolution, 
	  
Figure 1: C. diff pathogen and pseudomembranous colitis.    
A: Scaled image of the Clostridium difficile microbe.4 B: Image 
of a normal, healthy colon.5 C: Yellow plaques characteristic of 
pseudomembranous colitis in a diseased patient.6 	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prevalence and mortality rates associated with CDAD are actively increasing, with susceptibility 
relying not only on antibiotic consumption and hospitalization, but elderly individuals and those 
with inflammatory bowel disease (IBD) or human immunodeficiency virus (HIV) are also 
especially vulnerable.12 Roughly 500,000 Americans per year acquire CDAD, where 1 out of 
every 5 patients experience a recurrent infection, and nearly 30,000 of the overall infected 
patients die within only one month of disease onset.13 Notably, 80% of yearly deaths due to C. 
diff infection occurred among those aged 65 years and above.13 Furthermore, the number of 
CDAD victims has recently outgrown those infected with methicillin-resistant Staphylococcus 
aureus  (MRSA), causing CDAD-related medical expenses to reach $4.8 billion in the United 




Figure 2: Cycle of CDAD manifestation and recurrence. Broad-spectrum antibiotics lead to the disruption 
and modification of the normal microbiota in the gut, which subsequently allows C. diff to colonize. If the host 
immune system is efficient enough to fight off the infection, then CDAD will be nullified. However, if the 
immune system is compromised, C. diff will be allowed to release toxins, cause mucosal damage and 
inflammation within the gut, and eventually evolve fully to CDAD. At this stage, the disease cycle is continued 
via patient-to-patient transmission.11 	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Enterotoxins A (TcdA) and B (TcdB), shown in Figure 3, are the main virulence factors 
produced by C. diff.10 Both TcdA/B are composed of four domains: an enzymatic 
glucosyltransferase domain (GTD), a cysteine protease domain (CPD), a central translocation 
domain (TD), and a receptor-binding region at the c-terminus, also known as the C-terminal 
repetitive oligopeptide receptor-binding domain (CROP-RBD).15 The tcda and tcdb genes 
encoding Toxin A and B, respectively, are located within a 19.6 kb chromosomal region known 
as the pathogenicity locus (PaLoc).19 Also present within the PaLoc is tcdr and tcdc, which are 
genes that code for a positive and a negative transcriptional regulator of toxin production, 
respectively, and tcde, a holin-like protein necessary for secretion of the toxins into the 
 
Figure 3: Clostridium difficile’s primary virulence factors. The proteinaceous enterotoxins A (TcdA, top) and 
B (TcdB, bottom) produced by C. diff are shown above with corresponding molecular weights to the left. Both 
toxins are composed of four domains (GTD, red; CPD, blue; TD, orange; CROP-RBD, green) and differ mostly 
in the length of their CROP-RBD regions. Each domain is labeled with the chronological number of amino acid 
residues, beginning at the N-terminus. The recently determined crystal structure of the first three domains is 
shown below (PDB: 4R04)16 as well as a segment of the TcdA CROP-RBD (PDB: 2F6E), which consists of 32 
short repeats and 7 interspersed long repeats (light blue).17, 18	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surrounding environment. These three additional PaLoc genes, although extremely important, are 
only a few of many factors involved in the regulatory networks of TcdA/B synthesis.19 
Pathogenesis of TcdA/B is exceptionally fascinating; these holotoxins possess all 
necessary machinery required to infect and kill cells. The mechanism of action (Figure 4), 
although yet to be completely understood, proceeds by first utilizing the CROP-RBD to bind a 
glycan receptor present at the surface of colonic epithelium cells.20 More specifically, the CROP 
has portrayed specific binding affinity to glycan moieties ending in a Galα1,3Galβ1,4GlcNAc 
sequence, where the α1,3 linkage amidst the two galactose sugars is suggested to be of 
importance.22 Upon binding, receptor-mediated endocytosis is activated and results in an 
Figure 4: Mechanism of TcdA/B pathogenesis. A: Diagram of TcdA domains. B: Pathogenesis begins when 
the CROP-RBD (green) binds a receptor and initiates endocytosis (1). As the endosomal pH drops, the TD 
(orange) forms a pore-like structure that traverses the endosomal membrane. Next, the N-terminus translocates 
into the cytosol (2), IP6 (black hexagons) causes self-cleavage of the CPD (blue) (3), and the GTD (red) is 
released. Finally, the GTD enzymatically glucosylates Rho-GTPase proteins (purple) and causes cell death (4).21	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endosome-encapsulated toxin.23 The acidic environment, which is characteristic during 
endosomal maturation, then allows the TD to unfold, expose its hydrophobic residues, and insert 
into the endosomal membrane, forming a pore-like structure that acts as the pathway for 
endosomal release.20, 24 Beginning at the N-terminus, the GTD and CPD are fed through the pore 
and into the cytosol.24, 25 The mechanism of endosomal insertion and release is still not 
completely known, but is believed to proceed in a way very similar to that of the anthrax toxin 
produced by Bacillus anthracis.26 Upon entering the cytosol, the CPD binds native inositol 
hexakisphosphate (IP6), which causes a conformational change allowing self-cleavage of the 
CPD and release of the enzymatic GTD.24 The GTD is then free to exploit native UDP-glucose 
(UDP-Glc) as a substrate by hydrolyzing UPD-Glc and transferring the glucose moiety to 
threonine 37 of Rho GTPase family members (RhoA, Rac1, Cdc42) residing within intestinal 
epithelium cells.27 Glycosylation of these small proteins (5-20 kDa) inactivates the enzymes 
catalytic GTP-ase behavior, resulting in loss of tight junctions between cells, loss of intestinal 
barrier function, cell death, and the characteristic symptoms of CDAD.8 
The vigorous manifestation of C. diff and production of toxins also causes activation of 
the host immune system.28, 29 As a first line of defense, the innate immune system generates non-
specific immunity by producing small proteins, called cytokines, which lead to numerous 
downstream signaling events within the cell.30 Cytokines, such as interleukins and chemokines, 
work together to identify and remove foreign matter by recruiting immune cells to the infection 
site, balancing humoral and cell-based immunity, and activating the adaptive immune system.30, 
31 A compromised immune system in combination with existing C. diff infection is unfavorable 
and will likely progress illness within the patient,  however an overactive immune system can 
also be destructive by initiating an excessive inflammatory response that may damage healthy 
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tissue. Therefore, although innate immunity is designed to fight off infection, when regarding C. 
diff and CDAD patients, in fact the system most often produces a detrimental amount of colonic 
inflammation that enhances disease progression.2, 32 Consequently, the problem and/or cure of 
CDAD becomes two-fold; both host and pathogen play a synergistic role in C. diff disease 
pathogenesis and progression.32 In other words, inhibition of bacterial colonization and toxic 
virulence factors, as well as down-regulation of harmful inflammation in response to C. diff 
bacterial components is needed to elicit an efficient therapeutic remedy. 
A few of the current treatment methods to combat CDAD include antibiotic therapy, fecal 
transplantation, probiotics, and immunotherapy.1, 33, 34 Antibiotics, such as vancomycin and 
metronidazole, are usually the first course of action against the C. diff pathogen, however this 
approach has shown to have high recurrence rates and is also responsible for numerous resistant 
and hypervirulent strains.1 Probiotics and fecal transplantation are both methods that attempt to 
reestablish the normal microflora within the gut, which is essential for diminishing C. diff and 
curing the patient. Although probiotic and fecal transplantation therapies have had some success, 
they both have downfalls as well. Probiotics, which are still considered to be controversial (not 
always FDA regulated), are not typically potent enough to cure the infection on their own and 
therefore are usually administered in conjunction with other treatments.33, 34 On the other hand, 
fecal transplantation has had many good outcomes, however it is known to have low patient 
compliance, moderate recurrence rates, and risk of transferring disease or other physiological 
traits (obesity, depression, etc.) to the patient.1, 34, 35, 36  
In attempt to sequester and fight off toxins, immunoglobulin and/or monoclonal 
antibodies have had variable outcomes, however these therapies are often administered at 
extremely high, sometimes toxic doses and again, usually in conjunction with other treatment 
 7	  
	  
methods.1, 33, 34 It would be ideal to avert the disease altogether, however there has yet to be a 
preventative C. diff vaccine to pass clinical trials.1 With all things considered, the current 
treatment options are ineffective and neglect to simultaneously target the bacterial pathogen and 
the inflammation-causing virulence factors that have already been produced. Moving forward, an 
effective therapeutic method that will inhibit all factors of CDAD is needed. 
The specific goals of my thesis investigate GTD inhibition, host and pathogen 
contribution to immune system activation, and production of active rTcdB-WT.  To begin, the 
first project deals with the development of an epoxide-containing peptide (HQS-Epoxy) as a 
novel, covalent inhibitor of the glucosyltransferase activity of C. diff toxins A and B (Chapter 
2). Here, I aim to elucidate the rate of relative inhibition and crosslinking of the epoxide inhibitor 
to the GTD, the half-maximal inhibitory concentration (IC50) of the peptide, and visual 
confirmation of cell protection against rTcdA-WT when inhibitor is present. Secondly, in regards 
to the host immune system, a collaboration was formed with Dr. William Petri’s lab at the 
University of Virginia to elucidate the relationship between C. diff bacteria/toxin exposure and 
inflammasome activation within a murine host. Chapter 3 details in vitro and in vivo activation 
of inflammation and cytokine production, as well as in vivo cellular damage, in response to 
active rTcdA-WT. Finally, since toxin B was not yet available in the Feig Lab, Chapter 4 
outlines the cloning, expression, and purification of rTcdB-WT and rTcdB-NVN (catalytically 
inactive mutant), as well as in cellulo confirmation of rTcdB-WT cytotoxicity. Together, these 
studies can facilitate characterization of CDAD as a whole, as well as distinguish the potential of 








CHAPTER TWO:  
Irreversible Inhibition of Clostridium difficile Toxin A Glucosyltransferase Activity via an 
Epoxide-Containing Peptide 
As described in Chapter 1, both C. diff and the virulence factors TcdA/B are responsible 
for activating the host innate immune system, initiating a detrimental inflammatory response, and 
causing excessive damage to the colon.37, 38 Current treatment methods, most of which are 
antibiotics that target C. diff, are only modestly effective at curing CDAD. As a result, methods 
of targeting and inhibiting TcdA/B directly have become a topic of interest. Each of the four 
domains of TcdA/B (GTD, CPD, TD, and CROP-RBD) play separate and significant roles 
within the mechanism of infection, thus any of them can be targeted for inhibition.  
With hopes of impeding initial CROP receptor-binding and entry of TcdA/B into host 
cells, Cherian, et al., have recently engineered a cell line that stably expresses glycan derivatives 
which can be used to identify potential therapeutics by determining specific, high-affinity glycan 
receptor-binders.22 Studies have also identified specific regions within the TD that are imperative 
for endosomal release of the toxin39 as well as molecules that disrupt pore formation and/or 
translocation across the membrane, either structurally or by inhibiting endosomal acidification, 
to culminate in an encapsulated toxin that is essentially nontoxic.40, 41 Furthermore, several 
molecules have been reported to inhibit autoprocessing/cleavage of the CPD, activate premature 
cleavage of the CPD (before entering host cell),42, 43, 44 and inhibit enzymatic activity of the 
GTD,41, 45, 46 and although numerous attempts to obstruct TcdA/B on a molecular level have 
revealed a better understanding of pathogenesis, none have led to a therapeutic antitoxin remedy 
that is effective towards curing CDAD in humans.  
Interested by the inherent and newly discovered inflammatory damage to the colon that is 
the result of the GTD, the Feig Lab is currently investigating methods of TcdA/B 
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glucosyltransferase inhibition. Previously, Dr. Sanofar Abdeen used the phage display technique 
to identify a heptapeptide (HQSPWHH) which exhibited nanomolar binding affinity to the GTD 
of C. diff rTcdA.11, 46 Transitioning from phage to free peptide involved addition of a flexible 
glycine linker and a C-terminal cysteine for future labeling and binding purposes, resulting in the 
amino acid sequence HQSPWHHGGGC. As expected, this peptide displayed inhibition of 
glucosyltransferase activity in vitro, however further studies unexpectedly showed that it lacked 
the ability to protect against rTcdA in cellulo,11 which was hypothesized to be the result of 
inhibitor dissociation during endosomal translocation. 
To prevent dissociation and create a covalent connection between the inhibitor and the 
GTD active site, the tryptophan at position 5 was replaced with allylglycine (HQS-Parent) and 
subsequently modified to comprise a reactive epoxide moiety (HQS-Epoxy) with cross-linking 
ability.11 The structure and derivatization process of HQS-Epoxy is depicted in Figure 5. Further 
	  
Figure 5: Structure and production pathway of the HQS-Epoxy peptide inhibitor. The parent peptide 
(HQS-Parent) is purchased with an allylglycine at the fifth position (red), a three-glycine linker (green) for 
flexibility, and a cysteine residue for future labeling. Iodoacetamide is used to amidate and protect the C-
terminal cysteine (blue) before treating with mCPBA to oxidize the allyl group to an epoxide at position five.  	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analysis of HQS-Epoxy determined that incorporation of the epoxide did indeed generate an 
irreversible inhibitor that was confirmed by mass spectrometry to cross-linked to the catalytic 
region of rTcdA-GTD11, 47 and after incubation of 30 minutes successfully protected against 
rTcdA in cellulo, demonstrating 95% cell protection at a concentration of 600 μM and a half-
maximal inhibitory concentration (IC50) of ~100 μM.11, 46 Kinetically, the binding of HQS-Epoxy 
to rTcdA is a two step process that combines reversible and irreversible inhibition as described in 
equation 1, 
! + !  !+1⇌!−1  !" !! !"*                                                     !".!  
        
that is partially competitive to UDP-Glc and RhoA substrates, where the inhibitory binding 
affinity constant (KI) for the reversible, loosely bound EI complex is defined as k-1/k+1 and k2 is 
the rate constant (i.e., cross-linking rate or rate of inactivation) corresponding to the tightly 
bound, covalent EI* complex containing inactivated enzyme. Because of its potential to 
dissociate (k-1), the initial EI complex formation is assumed to be a slower process than the 
subsequent time-dependent EI* complex formation which is irreversible and results in a loss of 
active enzyme over time.  
To further analyze these kinetic parameters and extent of glucosyltransferase inhibition 
generated by HQS-Epoxy, the optical coupled-enzyme assay displayed in Figure 6A was 
employed. With UDP being a common product of both GH and GT enzymatic reactions 
performed by rTcdA/B, this assay couples pyruvate kinase (PK) and lactate dehydrogenase 
(LDH) to allow for the simultaneous detection of the individual rates by monitoring the 
stoichiometric loss of NADH over time at an absorbance of 340 nm. Figure 6B depicts that 
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when RhoA or a suitable GTPase is present, TcdA/B exploits both GH and GT functionality and 




Figure 6: The coupled-enzyme assay 
simultaneously monitors glucosylhydrolase and 
glucosyltransferase activity conferred by of 
TcdA/B. A: UDP is the common product of both GH 
and GT reactions. Pyruvate kinase (PK) and lactate 
dehydrogenase (LDH) are coupled here, ultimately 
leading to the oxidation of NADH, which is 
monitored at A340 and stoichiometrically equivalent to 
the amount of UDP consumed. B: The GTD of 
TcdA/B acts on its UDP-Glc substrate in two specific 
manners. In the absence of Rho-GTPases, UDP-Glc 
is simply hydrolyzed, yielding separate UDP and 
glucose molecules (glucosylhydrolase activity (kGH), 
red). When s suitable accepter is present, UDP-Glc is 
hydrolyzed and transferred, resulting in a UDP 
molecule and an inactive, glucosylated GTPase  




RhoA is not present or has been diminished, the resulting rate is that of the GH reaction (kGH) 
alone, which can then be subtracted from kGH+GT to determine kGT. Pre-incubation of toxin with 
various concentrations of HQS-Epoxy inhibitor, and for specified times prior to assay initiation, 
was done to allow for a time-dependent analysis of GT inhibition and is discussed further below.  
 When using rTcdA-WT in the coupled-enzyme assay the slope of kGH+GT was determined 
to be -6x10-5 μmol/min (1.85 turnovers/min), as seen in Figure 7A/B, which is hypothesized to 
be the structural result of the holotoxin TD and CROP folding back and interacting with the GTD 
and CPD in a manner that obstructs enzymatic activity prior to acidification and cleavage.16, 48, 49 
Incubation of rTcdA-WT with IP6 has shown to induce cleavage and allow rTcdA-WT activity in 
vitro,48 however this was not attempted for the coupled-enzyme assay to avoid adding another 
enzymatic rate to the equation. Instead, in order to successfully analyze the GH and GT rates of 
C. diff toxin A, the GTD was isolated as a truncated construct containing the first 540 amino 
acids of the holotoxin (rTcdA540, Figure 8A).50, 51 As opposed to rTcdA-WT, rTcdA540 is fully 
 
Figure 7: kGH+GT rate of rTcdA-WT as determined by the coupled-enzyme assay and visual occlusion of 
rTcdA-GTD at high pH. A: Initial NADH turnover rate of rTcdA-WT (1.85 turnovers/min) where the slope of 
kGH+GT is -6x10-5 µmol NADH/min. B: Negative stain EM images reconstructed in 3D show structural changes 
in rTcdA upon decreasing pH.48, 49 GTD: red. CPD: blue. TD: yellow. CROP-RBD: green. 
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active when used in the coupled-enzyme assay and gives distinct rates for GH and GT (Figure 
8B), which have also been previously reported.11   
 Although analysis of rTcdA inhibition via HQS-Epoxy was monitored in cellulo,11, 46 the 
overall extent of inhibition, crosslinking rate (k2), and additional kinetic parameters utilizing the 
coupled-enzyme assay and rTcdA540 needed further investigation. Since the GH rate is slow and 
minimally affected by HQS-Epoxy, an average GH rate of 15 ± 1 turnovers/min (n = 4) was 
determined for rTcdA540 in the absence of inhibitor (data not shown). Once observed kGH+GT rates 
in the absence and presence of varying HQS-Epoxy concentrations were determined, the average 
GH rate of 15 ± 1 turnovers/min was subtracted to give the average initial GT turnover rates seen 
in Figure 9A. At time zero, the GT rate of rTcdA540 (~140 turnovers/min) showed little change 
regardless of inhibitor concentration, but continuous incubation of rTcdA540 with HQS-Epoxy at 
	  
Figure 8: Structure and distinct enzymatic rates of rTcdA540. A: Shown on top, rTcdA540 contains amino 
acids 1-540 of the TcdA holotoxin producing a 66 kDa protein. Below, the structure of the GTD (PDB: 3SRZ)51 
is displayed with catalytic residues D286 and D288 in green and UDP-Glc in blue. B: Example of data obtained 
from the coupled-enzyme assay using rTcdA540, where kGH+GT is shown in purple with a slope  of -0.00590 





37 °C resulted in decreasing GT activity over time, indicating that the crosslinking process is not 
occurring instantaneously and is in fact time-dependent. Figure 9A also shows that although 
rTcdA540 lost roughly 50% activity over the 60 minute time course in absence of inhibitor, there 




Figure 9: rTcdA540 glucosyltransferase rates for varying inhibitor concentrations over time. A: rTcdA540 
(325 nM) was incubated with 0, 50, 100, 300 or 600 µM inhibitor at 37 °C for the duration of 1 hour. Aliquots 
from each sample were taken at 0 (blue), 15 (red), 30 (green), and 60 min (purple) and added to the coupled-
enzyme assay to determine glucosyltransferase activity, shown here as inverse minutes. B: Relative rates (vi/vo) 
for varying HQS-Epoxy concentrations (µM) at 0, 15, 30, and 60 minute time points. C: Percent inhibition of 




time period. These data suggest that rTcdA540 loses enzymatic activity over the 60 minute time 
course when incubated at 37 °C. However, this effect is not the sole reason for the decrease in 
GT rate that is seen in presence of the inhibitor. 
To account for loss of rTcdA540 activity over time, Figure 9B portrays the relative rate 
(vi/vo) as a function of the corresponding pre-incubation time where vi is the GT rate in presence 
of inhibitor, vo is the GT rate in absence of inhibitor, and vi equals vo when [inhibitor] = 0. 
Representation of the kinetic data in this manner visually clarifies that 600 μM inhibitor results 
in roughly 95% inhibition, agreeing with previously reported in cellulo data.11 Figure 9B also 
exhibits that nearly 100% of potential crosslinking occurs in less than 15 minutes as longer 
incubation times of 30 and 60 minutes did not confer additional inhibition, thus suggesting an 
upper limit of 1.3 min-1 for the rate constant k2. Supplementary data at time points below 15 
minutes are necessary to more accurately define the rate constant of the crosslinking event.  
Nevertheless, IC50 values for the specified pre-incubation times were obtained by fitting 
the data in Figure 9B to a generic half-life equation,  
!! = !! ∙ 12 !!! !                                                                    !".!  
where Nt is the quantity remaining after time t, No is the initial quantity, and t1/2 is the half-life. In 
this case however, when relative rates are plotted with inhibitor concentration on the x-axis, t1/2 
then becomes the inhibitor concentration at 50% of the initial quantity, also known as the half-
maximal inhibitory concentration or IC50. Following Krippendorff, et. al.,52 to determine KI and 
k2 variables, time-derived IC50 values were then graphed against time (Figure 9C) and fit by 
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where IC50(t) is the half-maximal inhibitory concentration at time t, S is the substrate 
concentration (RhoA), and KM is the Michaelis-Menten constant for RhoA.11, 50 All variables used 
and/or derived from fitting the model equations 2 and 3 can be seen in Table 1. 
 
In comparison to previously reported values,11 the obtained KI of ~1100 μM is roughly 
3.5 orders of magnitude larger than that found for HQS-Parent (KI = 300 nM) and one order 
larger than the IC50 (100 μM) of HQS-Epoxy.11 An increase in the KI value was expected due to 
decreased binding affinity of the modified peptide following addition of the epoxide moiety, 
however it is also important to note that these values were obtained using different experimental 
methods and fitting models. Furthermore, confirming that crosslinking was nearly complete by 
the 15 minute time point (Figure 9B), combined with the lack of GT data corresponding to 
critical time points below 15 minutes, the k2 value was somewhat expected to be inaccurate. 
Presumably, the determined k2 of 1.3 min-1 is seemingly slow, reflecting an upper limit of this 
value and indicating that EI* is formed at a constant rate of 1.3 crosslinking events per minute. 
Again, this data is unable to be published because time points below 15 minutes are necessary to 
accurately determine the values of KI and k2.  
0 min 15 min 30 min 60 min
2487.7 409.4 357.6 355.2 50 300 1066.5 1.3
aRhoA substrate concentration used in assays. bMichaelis-Menten constant for RhoA affinity to TcdA11, 50
Table 1: Kinetic variables for HQS-Epoxy inhibition of rTcdA540.
Time-derived IC50 Values (µM) S (µM)a KM  (µM)b KI  (µM) k2 (min-1)
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 To visualize if HQS-Epoxy confers cell protection against rTcdA at an incubation time 
point of zero, toxin and inhibitor were mixed and immediately subjected to Vero cells for 1 hour 
before imaging. Contrary to the GT kinetics reported above, Figure 10 shows that even with 
zero pre-incubation time allotted for crosslinking, the majority of cells were alive and protected 
from the rounding effects of rTcdA, but in the absence of HQS-Epoxy, cells containing 0.2 nM 
rTcdA were severely disrupted and nearing death after only 1 hour. These data verify the fact 
that HQS-Epoxy crosslinks to the GTD in less than 15 minutes and most likely does so following 
CROP-receptor binding and endosomal acidification, as the TD and CROP interact with the 
GTD prior to these events,16, 48, 49 which was corroborated by the lack of activity for rTcdA-WT in 
the coupled-enzyme assay. Moreover, incubation of Vero cells with 600 μM HQS-Epoxy alone 
determined that the epoxide-containing peptide inhibitor is in fact not toxic to cells and further 
validates its potential use as an antitoxin therapeutic.  
	  
 
Figure 10: Visual cell protection against rTcdA in presence of HQS-Epoxy inhibitor. Vero cells were 
grown to confluency at 37 °C and 5% CO2 and images were taken at time zero (top row) before addition of 0.2 
nM rTcdA-WT (column 2), 0.2 nM rTcdA-WT and 600 µM inhibitor (column 3; no preliminary incubation time 
allotted), or 600 µM inhibitor alone (column 4). Cells were then incubated at 37 °C and 5% CO2 for 1 hour 
before imaging again (bottom row). After 1 hour, cells in column 1 (control; media only) show no change as 
expected. Cells in column 4 remain flat and adherent, indicating that 600 µM inhibitor does not seem to harm 
cell viability. Following incubation with 0.2 nM rTcdA-WT, Vero cells are rounded, detaching from surface, 
and showing signs of cell death, however, majority of Vero cells are protected and remain adherent with 
addition of inhibitor. 	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The contrast of in vitro and in cellulo inhibitor effects at time zero are not extremely 
surprising, however; since the inhibitor peptide cannot bind rTcdA-WT before receptor binding 
and/or conformational change from endosomal acidification, there is an intrinsic delay in EI and 
EI* complex formation that may account for this phenomenon. Further, the pH dependence on 
crosslinking rate (k2) has yet to be determined. It may initially be assumed that alkaline pH 
values will have an additive effect on k2 by increasing the nucleophilicity of the amino acid that 
crosslinks to the active site,11 but it can also be suggested that low pH may result in protonation 
of the epoxide moiety thereby increasing the electrophilic nature and enhancing k2 as well. 
Future GT inhibition studies with varying pH will be useful in determining the pH-dependent 
effects on KI and k2. Lastly, it is known11 that HQS-Epoxy is somewhat competitive in respect to 
UDP-Glc and RhoA, the concentrations of which are higher than that of biological environments 
during the in vitro assay, and may also confer inhibition of HQS-Epoxy binding to some extent.  
Future analysis of HQS-Epoxy in vivo, potentially within a mouse model, is needed to 
determine extent of inhibition, toxicity levels, stability of the peptide, and persistence of 
inhibitory impact when in a biological environment. Moreover, since HQS-Epoxy portrays a 
binding affinity and IC50 within the high μM range, a future reselection process to identify a 
mimicking peptide with nM affinity may be beneficial. Determining more accurate values for KI 
and k2 between 0 and 15 minutes, as well as the pH-dependence imposed on these variables, will 
also further characterize the epoxide-containing peptide and in doing so, these studies will help 









CHAPTER TWO METHODS 
 B. meg protoplast generation. All procedures containing B. meg were carried out in a 
Biosafety Level 2 (BL2) lab following standard operating procedures. B. meg cells were grown 
overnight in 5 mL Difco™ Antibiotic Medium 3 (AB3) at 37 °C and 250 rpm. Fresh, warmed 
AB3 medium (50 mL) was then inoculated with 1 mL of overnight culture and incubated at 37 
°C and 250 rpm until an A550 of 1.0 was reached. Cells were harvested (2000 rpm, 10 min, 
ambient temp), resuspended in 5 mL SMMP (1:1 AB3/SMM (40 mM maleic acid, 80 mM 
NaOH, 40 mM MgCl2, 1 M sucrose)), and transferred to a 100 mL flask before adding 2 mg/mL 
lysozyme and incubating (37 °C, 100 rpm, 45-60 min). Again, cells were harvested (2250 rpm, 
10 min, ambient temp), washed with 5 mL SMMP, and harvested once more as before. Finally, 
cells were resuspended in 5 mL SMMP (containing 10% (w/v) glycerol) and aliquoted before 
storing at -80 °C. Protoplasts were visualized by phase-contrast microscopy. 
 B. meg plasmid transformation. B. meg protoplasts (200 μL) were thawed and 0.5-1 μg 
of E. coli miniprepped-plasmid DNA was added, followed by addition of 600 μL PEG-P (40% 
(w/v) PEG6000, 500 mM sucrose, 20 mM sodium maleinate, 20 mM MgCl2, pH 6.5) solution 
was inverted to mix. Cells were incubated on ice and then at room temperature for 2 min each, 
followed by addition of 2 mL SMMP, gentle inversion, and harvesting (3000 rpm, 10 min, 
ambient temp). Supernatant was removed and 500 μL fresh SMMP was added before outgrowing 
at 37 °C and 100 rpm for 90 min. Transformed culture was finally mixed with topagar, plated 
(LB agar plus 10 μg/mL tetracycline (tet)), and incubated at 37 °C for 16 hours. Colonies were 
restreaked on tet plates to ensure selection.  
rTcdA/B protein expression and purification. B. meg cells containing the rTcdA/B 
plasmid were first grown overnight (37 °C, 250 rpm, 16-19 hours) in 10 mL LB containing 10 
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μg/mL tet before inoculating 1 L LB flasks (10 μg/mL tet) with the 10 mL overnight culture. 
Cells were then grown to OD600 of 0.4, induced by addition of 0.5% D-xylose, and incubated to 
OD600 of 1.5. Cells were harvested (8500g, 10 min, 4 °C) and stored at -80 °C until use. Thawed 
cell pellets (1-2 L) containing lysis buffer (50 mM Na2HPO4, 300 mM NaCl, 10 mM imidazole, 
pH 8) and protease inhibitors were lysed by sonication (5 cycles at 37% power) and centrifuged 
to clarify (15,000 rpm, 45 min, 4 °C). Supernatant was filtered through 0.8 μm and 0.22 μm 
syringe filters, respectively, before removing from BL2 constraint. Crude lysate was purified 
first via nickel affinity column chromatography, followed by size exclusion column 
chromatography and a second affinity column to concentrate the protein. Affinity columns were 
washed with increasing concentrations of imidazole and elution was achieved with 250 mM 
imidazole. Lysates were filtered through 0.22 μm filters after each chromatography step and 
preceding dialysis (10,000 MWCO) into storage buffer (50 mM HEPES-K, 100 mM KCl, 1 mM 
MgCl2, pH 7.5). 
rTcdA540 protein expression and purification. BL21 DE3 E. coli cells containing the 
rTcdA540 plasmid (pNLA 20405;50 transformed via electroporation) were first grown overnight 
(37 °C, 250 rpm, 16-19 hours) in 10 mL LB containing 10 μg/mL amp and 34 μg/mL cam before 
inoculating 1 L LB flasks (10 μg/mL amp and 34 μg/mL cam) with the 10 mL overnight culture. 
Cells were then grown to OD600 of 0.4-0.6, induced by addition of 1 mM IPTG, and expressed 4-
5 hours. Cells were harvested (5500g, 10 min, 4 °C) and stored at -80 °C until use. Thawed cell 
pellets (1-3 L) containing lysis buffer (50 mM Na2HPO4, 300 mM NaCl, 10 mM imidazole, pH 
8) and protease inhibitors were lysed by sonication (5 cycles at 37% power) and centrifuged to 
clarify (10,000 rpm, 45-60 min, 4 °C). Supernatant was filtered through 0.8 μm and 0.45 μm 
syringe filters, respectively, before removing from BL2 constraint. Crude lysate was purified 
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first via nickel affinity column chromatography, followed by size exclusion column 
chromatography and a second affinity column to concentrate the protein. Affinity columns were 
washed with increasing concentrations of imidazole and elution was achieved with 250 mM 
imidazole.  Lysates were filtered through 0.22 μm syringe filters after each chromatography step 
and preceding dialysis (10,000 MWCO) into storage buffer (50 mM HEPES-K, 100 mM KCl, 1 
mM MgCl2, pH 7.5).  
RhoA GTPase expression and purification. Rosetta 2 (DE3) E. coli cells containing the 
RhoA-v4 plasmid (pNLA 20504;50 transformed via electroporation) were first grown overnight 
(37 °C, 250 rpm, 16-19 hours) in 10 mL LB containing 30 μg/mL kan and 34 μg/mL cam before 
inoculating 1 L LB flasks (30 μg/mL kan and 34 μg/mL cam) with the 10 mL overnight culture. 
Cells were then grown to OD600 of 0.4-0.6, induced by addition of 1 mM IPTG, and expressed 4-
5 hours. Cells were harvested (5500g, 10 min, 4 °C) and stored at -80 °C until use. Thawed cell 
pellets (1-3 L) containing lysis buffer (50 mM HEPES, 300 mM NaCl, 1 mM MgCl2, pH 8) and 
protease inhibitors were lysed by sonication (5 cycles at 37% power) and centrifuged to clarify 
(10,000 rpm, 45-60 min, 4 °C). Supernatant was filtered through 0.8 μm and 0.2 μm syringe 
filters, respectively. Crude lysate was purified via nickel affinity column chromatography, 
washed with increasing concentrations of imidazole, and eluted with 150 mM imidazole.  
Lysates were filtered through a 0.22 μm syringe filter preceding dialysis (3500 MWCO) into 
storage buffer (50 mM HEPES-K, 100 mM KCl, 1 mM MgCl2, pH 7.5). Protein was 
concentrated (3500 MWCO) if necessary. 
Optical coupled-enzyme assay. Reactions contained 50 μM RhoA, 0.5 mM UDP-
Glucose, 35 units/mL pyruvate kinase, 75 units/mL lactate dehydrogenase, 1 mM PEP, and 0.2 
mM NADH in storage buffer (50 mM HEPES-K, 100 mM KCl, 1 mM MgCl2, pH 7.5). Toxin 
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(rTcdA540 or rTcdA-WT) at concentrations ranging from 32.5-325 nM, with or without inhibitor 
present, was added to initiate the reaction (100 μL final volume) at 0, 15, 30 and 60 min time 
points, and the decline of A340 was monitored using an Agilent 8453 UV-VIS spectrophotometer 
equipped with a circulating water bath set to 37 °C. For inhibition studies, 50, 100, 300, or 600 
uM HQS-Epoxy inhibitor peptide was used. Reactions were incubated at 37 °C over the duration 
of the experiment. 
HQSPGallylHHGGGC-NH2 peptide protection, epoxidation and purification. 11 
HQSPGallylHHGGGC-NH2 (HQS-Parent) was purchased from American Peptide, resuspended to 
a final concentration of 1 mg/mL in 20% ACN/H20, and purified by reverse-phase high-
performance liquid chromatography (RP-HPLC) using a semi-preparative C-18 column (5-65% 
linear gradient of 0.1% TFA/ACN, flow 1.00 ml/min). Peptide fractions were collected, flash-
froze via liquid nitrogen, and lyophilized overnight. A 1:1 molar ratio of dried HQS-Parent 
peptide and DTT was dissolved in 0.1 M (NH4)2CO3 buffer pH 8, flushed with N2 and incubated 
at 54 °C for 30 min.  Next, solid iodoacetamide was added in 10-fold molar excess. Reaction was 
kept under N2 in the dark, with continuous stirring for 2 hours, and then purified by RP-HPLC 
and lyophilized as above. Keeping under N2, dried HQS-Protected peptide and 10-fold molar 
excess m-chloroperoxybenzoic acid (mCPBA) was added to a stirred solution of 2:1 CH2Cl2:0.01 
M Na2HPO4/NaH2PO4 buffer pH 8, and incubated at room temperature with continuous stirring 
for at least 5 hours. Reaction progress was monitored by thin-layer chromatography (mobile 
phase 7:2:1 NH4OH: H20: 2-propanol). Peptide was precipitated and washed 6 times by addition 
of diethyl ether to the aqueous layer. Peptide was then lyophilized, redissolved in water, and 
desalted by addition of ACN (50% v/v), centrifugation (4 °C, 10,000g, 10 min), and removal of 
supernatant from salt pellet. Again, peptide was purified as above, lyophilized, and stored at -20 
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°C until use. Mass spectrometry after each step determined presence of peptide. 
Vero cell cultures. All procedures containing Vero cells were carried out in a Biosafety 
Level 2 (BL2) lab following standard operating procedures. Vero cell glycerol stocks were 
removed from -80 °C and quickly (less than 1 min) warmed to 37 °C in a water bath. Cells were 
suspended in 6 mL warm Eagle’s Minimum Essential Media (EMEM) enriched with 10% fetal 
bovine serum (FBS) and 1% Antibiotic-Antimycotic (Anti-Anti) and spun down (200g, 5 min, 
ambient temp). Media was removed from pellet and cells were resuspended in 3 mL fresh media, 
which was plated in a 25 mL culture flask and incubated at 37 °C and 5 % CO2. Once grown to 
roughly 80% confluency, adherent cells were passaged and regenerated as followed: EMEM was 
removed and 0.5 mg/mL trypsin was added before incubating the flasks at 37 °C and 5% CO2 for 
3 minutes or less. Trypsinized cells were then diluted 3X with EMEM, harvested (200g, 5 min, 
ambient temp), resuspended with 5 mL EMEM and new culture flasks were seeded with 50 μL 
resuspended cells and 3 mL fresh EMEM before incubating as before. Newly plated cells from 
glycerol stocks underwent a minimum of three passages before being used in any experiments. 
Visual cell protection assay. Vero cells were seeded in a clear, 12-well plate in 500 μL 
Eagle’s Minimum Essential Media (EMEM) enriched with 10% fetal bovine serum (FBS) and 
1% Antibiotic-Antimycotic (Anti-Anti), incubated at 37 °C and 5 % CO2, and grown to roughly 
80% confluency. Wells were imaged using a Nikon Eclipse TS100 (Nikon Intensilight C-HGFI) 
and washed twice with 1 mL serum-free EMEM (SF-EMEM supplemented with 1% Anti-Anti) 
before adding either SF-EMEM alone, 0.2 nM rTcdA-WT, 0.2 nM rTcdA-WT plus 600 μM 
HQS-Epoxy peptide inhibitor, or 600 μM HQS-Epoxy peptide inhibitor topped off with SF-
EMEM to a final volume of 500 μL. Cells were then incubated (37 °C, 5 % CO2) for 1 hour 
before imaging again. 
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CHAPTER THREE:  
Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A38 
In effort to further understand the role of immune system activation in CDAD, the Feig 
Lab collaborated with the Petri Lab in the Immunology Department at the University of Virginia. 
The Petri Lab has recently reported evidence of elevated levels of specific proinflammatory 
cytokines (IL-23 and IL-1β) that enhance disease progression in specimens positive for C. diff 
infection.37, 53 Furthermore, Cowardin, et al., allude to the fact that activation of a robust 
inflammatory response is the result of not only C. diff toxins, but also the presence of a necessary 
precursor, or “priming” signal, brought on by bacterial components known as pathogen-
associated molecular patterns (PAMPs).37 Since part one of my thesis project deals solely with 
inhibition of GTD, the recent discoveries from the Petri Lab are of particular interest to me, not 
to mention the fact that they have access to mouse models. Moreover, the experiments in the 
Petri Lab, until now, were done with naturally isolated C. diff toxins, but that precludes the use 
of modified and mutant toxins, which provide a more granular probe of toxin activity. With the 
Feig Lab’s background in biochemistry, the Petri Lab’s knowledge of immunology, and the 
common interest of CDAD, a collaborative partnership was formed. Goals of this collaboration 
included further mechanistic understanding of inflammasome activation upon C. diff exposure, 
specific pathways involved in inflammation upregulation, and specific players associated with 
these pathways, which can be seen in Figure 11.  
A previous lab member, Dr. Amy Kerzmann, genetically modified wild type rTcdA by 
site-directed mutagenesis to produce an enzymatically-inactive mutant, named rTcdA-NVN, 
with commonly known D285N and D287N mutations.50, 54 To begin collaboration with Carrie 
Cowardin in the Petri Lab, expression plasmids containing these genes (rTcdA-WT, 
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pANK_80406; rTcdA-NVN, pANK_80407) were transformed into Bacillus megaterium (B. 
meg), expressed, and purified before shipping to the University of Virginia. Final SDS-PAGE 
gels depicting the purity of these proteins are shown in Figure 12A. The final elution fraction 
(E*) containing the toxins also shows the presence of a protein band just below rTcdA that was 
unable to be resolved and separated with the size-exclusion column in our lab due to very similar 
molecular weights. Also existing in the E* lane is a band below 72 kDa, which was previously 
identified by mass spectrometry11 to be the 63 kDa GTD that is produced by self-cleavage of 
rTcdA at the CPD. The higher molecular weight positioning on the gel is most likely due to 
different charge distribution within the molecules. Although not yet tested by mass spectrometry, 
it would seem apparent then that the small band above 170 kDa and below rTcdA is likely rTcdA 
with the loss of GTD (roughly 245 kDa) after self-cleavage. 
	  
Figure 11: Overview and key components of C. diff immune system activation pathways. C. diff PAMPs 
and toxins produced after colonization activate the host innate immune system by initiating cytokine production 
and recruiting immune cells (macrophages, mast cells, monocytes, etc.) to the site of infection. Immune cells 
subsequently express more cytokines, creating a positive feedback loop. The proinflammatory cytokines IL-6 
and pro-IL-1β are produced mainly by monocytes; IL-6 results in the recruitment of other immune cells (B 
cells, T cells, natural killer (NK) cells, and neutrophils) while pro-IL-1β becomes IL-1β after caspase 1 
cleavage.55, 56 IL-1β then binds to dendritic cell surface toll-like receptors (TLR) where it initiates expression of 
the NF-κB protein complex, a transcriptional regulator, which in turn upregulates proinflammatory cytokines, 
such as CXCL1.57, 58, 59 
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rTcdA-WT and NVN mutant were assayed for activity by the CellTiter-Glo® 
Luminescent Cell Viability Assay.60 Data in Figure 12B shows decreasing ATP concentrations 
(shown as relative light units; RLU) in the presence of increasing rTcdA-WT, indicating 
functional glucosyltransferase activity and loss of cell viability, where the cell population was 
killed with a half-maximal inhibitory 
concentration (IC50) near 0.7 nM. Cell 
viability is also reduced with 
increasing rTcdA-NVN, however cell 
death is significantly less than that 
seen for rTcdA-WT treatment, and is 
most likely due to toxicity from leaky 
endosomes since pore formation is still 
occurring. Furthermore, increasing the 
concentration of toxin results in less 
volume of media per well, which may 
also contribute to cell death. Although 
utilization of a wider concentration 
range of these toxins would have 
yielded more valuable data in Figure 
12B, a visual verification of rTcdA-
WT activity can also be seen in Figure 13. Phase-contrast microscopy displays rounding of 
HeLa cells after a 24-hour incubation period with 0.2 nM rTcdA-WT, indicating apoptosis and 
cell death.  
	  
	  
Figure 12: Purity and activity of rTcdA-WT and rTcdA-
NVN. A: SDS-PAGE gels after purification of rTcdA-WT 
(left) and NVN (right).  M: protein marker, F: column 
flowthrough, B: wash fraction (20 mM imidazole), W: wash 
fraction (50 mM imidazole), E1: first elution fraction (0.5 mL, 
250 mM imidazole), E*: pooled elution fractions containing 
rTcdA (2.5 mL). Protein marker molecular weights are shown 
to the left and the arrows indicates the self-cleavage products. 
B: Graph of cell viability data after incubation with toxins. 
RLU: relative light units. Blue diamonds: rTcdA-WT; red 
squares: rTcdA-NVN; green triangles: cells with no toxin; 




recombinant toxins in Dr. 
Bill Petri’s lab, in vitro 
experiments done by Dr. 
Carrie Cowardin38 with 
murine bone marrow 
derived dendritic cells 
(mBMDCs) and human 
THP-1 monocytes (hTHP-
1)37 indicated significantly 
elevated levels of CXCL1, 
IL-6, IL-1β, and caspase 1 after incubation with rTcdA-WT in comparison to NVN and controls 
(Figure 14A-B). CXCL1, also known as growth-related oncogene alpha or chemokine (C-X-C 
motif) ligand 1, is a chemokine (i.e., chemotactic cytokine) that uses methods of chemotaxis to 
recruit leukocytes to the site of inflammation and infection.57 IL-1β and IL-6, cytokines 
predominantly produced by monocytes, promote damaging inflammation via cellular infiltration. 
IL-1β is responsible for the induction of IL-6, as well as many other cytokines, and is even 
involved in a positive feedback loop for its own upregulation. IL-1β’s major contribution to 
inflammation comes from activation of the arachidonate/eicosanoid metabolism. Although IL-1β 
and IL-6 share many biological roles, IL-6 is further involved in stimulating B-lymphocyte 
maturation and T-cell regulation, particularly the differentiation of T-cells into cytotoxic T-
cells.55 Caspase 1, also named interleukin-1 converting enzyme (ICE), is responsible for the 
proteolytic cleavage of pro-IL-1β to its active IL-1β form.56 Figure 14B exhibits increased levels 
	  
Figure 13: Phase-contrast microscopy images of rTcdA-WT-treated 
HeLa cells. HeLa cells incubated with 0.2 nM rTcdA-WT (right) were 
imaged before (top) and after 24 hours (bottom). Control cells (left) were not 
treated with toxin. 	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of caspase 1, indicating a systemic inflammatory response upstream of IL-1β. Moreover, the 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, which is a 
blueprint of proinflammatory signaling, shows to be significantly triggered in the presence of 
rTcdA-WT (Figure 14C). Activated by cytokines, such as IL-1 and TNFα, this pathway 
involves several proteins acting as regulatory transcriptional factors for genes encoding 
proinflammatory cytokines, chemokines, and adhesion molecules, including CXCL1 mentioned 
above.58, 59 These data (recently published)38 indicate that glucosyltransferase activity is needed to 
induce such inflammatory responses, and in the case of caspase 1 and IL-1β, a priming signal is 
needed as well. 
Also done in the Petri Lab by Dr. Carrie Cowardin,38 injections of rTcdA toxin were 
	  
Figure 14: rTcdA-WT activates inflammasome and cytokine production in vitro. mBMDCs (A) and hTHP-
1 monocytes (B) were incubated with indicated concentrations of rTcdA toxins plus or minus LPS priming. 
Lysates were analyzed by ELISA for protein production after 24 hours. C: Murine RAW-Blue macrophages 
were subject to displayed rTcdA concentrations. SEAP levels reporting NF-κB activation were quantified in the 
culture media by the QUANTI-Blue assay at 24 hours.38 
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placed into the cecum of mice by laparotomy and 
subsequently subjected to cecal tissue analysis. Figure 15 
demonstrates the escalated appearance of cytokines 
(CXCL1, IL-1β, and IL-6) determined by ELISA, within the in vivo surroundings of the mouse 
colon. The destruction caused by rTcdA-WT and said proinflammatory cytokines can be 
visualized in Figure 16. Mice injected with rTcdA-WT show a significantly disrupted epithelial 
barrier in comparison to rTcdA-NVN and controls.  
The growing issue and prevalence of CDAD has shown to be more complicated than 
previously known. Not only does the C. diff pathogen play a major role in the disease, but recent 
evidence also shows the host immune system is partially to blame.32, 37, 53 These data demonstrate 
that the host immune system binds to and recognizes C. diff PAMPs as part of the priming 
	  
	  
Figure 15: rTcdA-WT initiates 
cytokine production in vivo. Indicated 
toxin (15 µg) was injected into the 
cecum of mice. After 8 hours, mice were 
sacrificed and cecal tissue lysates were 
analyzed for cytokine levels by ELISA. 
Each data point represents an individual 
mouse.38 
 
Figure 16: Histology report of mice cecal sections in 
response to C. diff rTcdA. Murine cecal sections were 
analyzed by hematoxylin-eosin staining after treatment with 
WT-rTcdA (top right) or NVN-rTcdA (bottom left). Control 
mice (Mock; top left) were not subject to either toxin. 
Quantitation of tissue damage for each group of mice is shown 
in the bottom right, where each data point represents one 
individual mouse (n = 8/group).38 
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process. However glucosylation of cellular targets by rTcdA is necessary to induce significant 
inflammation and cytokine production.38 These results further our understanding of how the C. 
diff glucosylating toxins and the host immune system act in concert to mediate CDAD colitis. 
The outcomes lend support to the ongoing development of toxin inhibitors, as this work shows 
that if delivered and dosed correctly, inhibited toxins would not activate the immune system in a 
manner that would damage the colon. This would also provide time for the patient to complete 
their course of primary antibiotics and undergo fecal transplantation to restore the gut 
microbiome to its initial state prior to the antibiotic therapy that allowed C. diff to colonize the 
patient’s GI tract. 
 
CHAPTER THREE METHODS 
HeLa cell cultures. All procedures containing HeLa cells were carried out in a Biosafety 
Level 2 (BL2) lab following standard operating procedures. HeLa cells were initially obtained 
from the Pflum Lab at Wayne State University. Cells were grown in 25 mL culture flasks 
containing Eagle’s Minimum Essential Media (EMEM) enriched with 10% fetal bovine serum 
(FBS) and 1% Antibiotic-Antimycotic (Anti-Anti) and incubated at 37 °C and 5 % CO2. Once 
grown to roughly 80% confluency, adherent cells were passaged and regenerated as followed: 
EMEM was removed and 0.5 mg/mL trypsin was added before incubating the flasks at 37 °C and 
5% CO2 for 3 minutes. Trypsinized cells were then diluted 3X with EMEM and harvested 
(1000g, 7 min, ambient temp). Cells were resuspended with 5 mL EMEM and new culture flasks 
were seeded with 50 μL resuspended cells and 3 mL fresh EMEM before incubating as before.  
Luminescent cell viability assay. CellTiter-Glo® luminescent reagents were purchased 
from Promega and the protocol was performed as previously described.60 Briefly, HeLa cells 
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(30,000 cells/well) were cultured in an opaque 96-well plate with fresh EMEM containing 10% 
FBS and 1% Anti-Anti and incubated overnight at 37 °C and 5% CO2. Cells were washed with 
serum-free EMEM (SF-EMEM) before addition of fresh SF-EMEM and varying concentrations 
of toxins to a total volume of 50 μL per well. Next, cells were incubated as above for 48 hours 
before cooling to room temperature, washing as above, and replacing fresh SF-EMEM (50-100 
μL) in wells. An equal volume of CellTiter-Glo® luminescent reagent was added, the plate was 
agitated (2 min, ambient temp), and then luminescent data was acquired using a GENios Tecan 
Microplate Reader. 
In vitro inflammasome activation and cytokine expression level determination. Carrie 
Cowardin, a collaborator in the Petri Lab at the University of Virginia, performed these 
experiments with rTcdA toxin provided by the Feig Lab (data recently published).38 Briefly, 
cultured mammalian cells (murine bone marrow derived dendritic cells, human THP-1 
monocytes, murine raw macrophages) were incubated for 24 hours with various concentrations 
of rTcdA-WT, rTcdA-NVN mutant, or neither (control), and in some cases lipopolysaccharide 
(LPS) as a priming signal. Cells were lysed and subject to ELISA to establish protein 
concentrations (CXCL1, IL-6, IL-1β, and Caspase 1). Quantitation of NF-κB upregulation i.e., 
inflammasome activation, was carried out with murine Raw-Blue™ macrophages, which are 
modified to contain a secreted embryonic alkaline phosphatase (SEAP)-reporter construct that is 
inducible by NF-κB. Culture media was surveyed by the QUANTI-Blue™ assay at A65061, 62 after 
24 hours. 
In vivo cytokine expression level determination. Carrie Cowardin from the University of 
Virginia performed these experiments.38 In brief, mice underwent a cecal laparotomy;63 meaning 
rTcdA-WT and rTcdA-NVN toxins were injected into the cecum (15 μg). After 8 hours, mice 
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were sacrificed. Cecal tissues were obtained, lysed, and the supernatant was subject to ELISA in 
order to quantitate cytokine production. 
Immunohistochemistry staining and histological analysis. Carrie Cowardin (University 
of Virginia) also performed these experiments. Again, toxin was injected to the cecum of mice 
via laparotomy. Mice were then sacrificed after 8 hours as above. Cecal tissues were obtained, 
fixed with Bouin’s solution (picric acid, acetic acid, formaldehyde) for 18 hours, embedded with 
paraffin for rigidity, sectioned, and stained with hematoxylin and eosin to visualize nuclei and 
the rest of the cell components, respectively.37, 38 Histology score was based on 5 parameters: 





CHAPTER FOUR:  
Cloning, Expression, and Purification of Clostridium difficile Recombinant Toxin B 
The homologous C. diff enterotoxins A and B share 48% sequence identity,64 and as seen 
in Figure 3, the main structural difference between the two resides within the length of the 
CROP domain. Although TcdA/B exhibit similar mechanisms of infection and enzymatic 
functions, TcdB is actually 100-fold more efficacious at initiating cytopathic cell rounding and 
apoptotic cell death,41 most likely attributed to a shorter CROP domain that is less able to 
occlude GTD and CPD activity.16, 48  Also in contrast to TcdA, high concentrations of TcdB have 
been shown to cause necrotic cell death via an alternative NADPH oxidase-mediated pathway, 
portraying the sudden depletion of cellular ATP, release of lactate dehydrogenase, and disruption 
of the cell membrane.41, 65, 66 Interestingly, the necrosis phenotype has been revealed to persist in 
cells treated with CPD/GTD-inactive TcdB mutants,65 indicating the sole necessity for 
functioning TD39, 64 and CROP domains.41 To further advocate the potential importance of TcdB-
induced necrosis regarding CDAD, studies show the elevated TcdB concentrations needed to 
exhibit this phenotype not only correlate to pathological colonic epithelial damage, but also 
compare to levels found in feces of clinical isolates with severe C. diff infection.65, 67 Lastly, there 
are numerous hypervirulent and resistant C. diff strains emerging today, such as the early 2000s 
epidemic strain NAPI/027/BI that is known for increased TcdA/B production (roughly 16-fold 
and 23-fold, respectively) and ribotype 017, which is a sole producer of TcdB (A-B+).1, 68, 69 
Because of the numerous aforementioned reasons, a more complete analysis of C. diff TcdB and 
therapeutic methods that successfully target this toxin are clinically important, and as all 
previous studies done in the Feig Lab have utilized C. diff TcdA, the cloning, expression, and 
purification of toxin B was needed.  
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Considering the great length of the TcdA/B genes, previous methods to clone rTcdA-WT 
and rTcdA-NVN in the Feig Lab included splitting the gene into segments to avoid possible 
errors in replication.53 Although this technique was successful, it is also strenuous and time 
consuming. To sidestep previous methods, the DNA polymerase used to clone rTcdB was 
upgraded to Q5® High-Fidelity polymerase, which has 3’ to 5’ exonuclease activity and an error 
rate of roughly 100-fold lower than taq and 
12-fold lower than pfu.70 Q5® polymerizes at 
an extremely fast rate of 6 kb/min and has 
shown to successfully replicate amplicons of 
less than or equal to 20 kb,71 which is more 
than 2.8 times the length of the targeted 
7101 bp tcdb gene. Furthermore, Q5® 
polymerase results in blunt ends, allowing 
for uncomplicated TOPO cloning, is 
effective at manipulating DNA via site-
directed mutagenesis,71 and has proven here 
to clone the entire tcdb gene without error. 
Full length TcdA/B proteins are 
rather large (308 kDa and 270 kDa, 
respectively) and do not express well in E. coli, therefore the Bacillus megaterium (B. meg) 
expression system (MoBiTec)72 known for oversized protein expression was used to provide a 
route for holotoxin production. The pHis1522 plasmid utilized in this system (Figure 17), 
possessing E. coli-specific ampicillin and B. meg-specific tetracycline resistance markers, is a 
	  
Figure 17: pHis1522 shuttle vector for B. meg 
expression system. The pHis1522 plasmid allows for 
ease of use between E. coli and B. meg, containing 
specific replication origins (grey) and antibiotic 
resistance genes (light blue) for each. Downstream of 
the xylose isomerase promoter (PxylA’, dark red), the 
multiple cloning site (magenta) is positioned in frame 
with the xylose isomerase gene (xylA’, purple) with 
specific BsrG1 and Kpn1 restriction cut sites shown in 
pink. Finally, the transcriptional regulatory repressor of 
xylose isomerase (xylR) is shown in cyan. 	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shuttle vector with relieved codon bias that allows for DNA manipulation in E. coli before 
transforming into B. meg for expression. Furthermore, the multiple cloning site within pHis1522 
contains a built-in C-terminal 6X his tag and is positioned within xylA’ (xylose isomerase-
encoding gene) to permit xylose induction of TcdA/B protein expression.72 
A general overview of the C. diff tcdb cloning process, borrowed closely from Feng, et 
al.,73 is illustrated in Figure 18. To begin, tcdb from C. diff genomic DNA (strain ATTC 9689D) 
was isolated and amplified by PCR utilizing Q5® High-Fidelity polymerase and primers 1 and 2 
	  
Figure 18: Overview of rTcdB-WT cloning process. The 7121 bp tcdb gene was isolated from C. diff genomic 
DNA (strain ATTC 9689D) and amplified via Q5® High-Fidelity DNA polymerase using primers 1 and 2, which 
were designed to contain 5’ BsrG1 and 3’ Kpn1 restriction digest sites for convenient ligation into pHis1522 
(7402 bp). Both tcdb and pHis1522 were purified, digested with BsrG1 and Kpn1 enzymes, and ligated together 
using T4 DNA ligase to give the final expression plasmid pBMJ_130401 (14458 bp). TSS: transcriptional start 




(Table 2), which were equipped with 5’ BsrG1 (primer 1; forward) and 3’ Kpn1 (primer 2; 
reverse) restriction digest sites for convenient ligation into the multiple cloning site of the 
pHis1522 shuttle vector. Following PCR, the expected amplicon size of 7121 bp (full tcdb gene 
length plus primer overhang) was confirmed by 
agarose gel electrophoresis and is shown in 
Figure 19, where all attempted temperatures 
within the gradient ranging from 49 °C to 61 °C 
were effective for primer annealing and 53.4 °C 
was used for subsequent scale-up PCR 
reactions.  
Once clean and quantified by A260, the 
C. diff tcdb amplicon and the shuttle vector 
pHis1522 were digested with BsrG1 and Kpn1 restriction enzymes, ligated together using T4 
DNA Ligase, and transformed into Top10 electrocompetent E. coli cells by electroporation. The 
ampicillin resistance marker within pHis1522 was used to select for transformant colonies 
containing viable plasmid, five of which were then isolated and purified. To confirm plasmid 
length prior to sequencing, Xho1 and Spe1 restriction enzymes with plasmid-specific and toxin-
specific cut sites, respectively, were used to confirm the correctly sized products of 8647 and 
Primer 
Number Name Primer Sequences
1 TcdB_F 5' - GCGCTGTACAATGAGTTTAGTTAATAGAAAAC - 3'
2 TcdB_R 5' - ATATATGGTACCCTTCACTAATCACTAATTGAGC - 3'
3 B2R_2 5' - TTAATCTTAGGTCTATCAGAAATTATACTTG - 3'
4 rTcdB_NVN_F2 5' - GAAATTGGTGGTATGTATTTAaATGTTaATATGTTACCAGGAATACAACCAGAC - 3'
5 rTcdB_NVN_R2 5' - GTCTGGTTGTATTCCTGGTAACATATtAACATtTAAATACATACCACCAATTTC - 3'
NOTE:  Bold: restriction enzyme site.  Underlined: primer binding complementary site.  Lower case: uncomplementary bases for SDM.
Table 2: Primers for cloning rTcdB-WT and rTcdB-NVN.
	  
Figure 19: The tcdb gene was successfully 
isolated from C. diff genomic DNA. Agarose gel 
shows successful amplification of the 7121 bp tcdb 
amplicon. All temperatures ranging from 49 °C-61 
°C resulted in effective annealing and 53.4 °C was 
used for following scale-up PCR reactions. 	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5811 bp (Figure 20). Primers shown in Table 3 subsequently verified the 7101 bp tcdb gene 
sequence to contain no errors. Finally, the tcdb-pHis1522 plasmid, now renamed pBMJ_130401, 
underwent transformation into B. meg for protein production. Figure 21 shows purified rTcdB-
WT at the correct size of 270 kDa, where a 16 hour expression period73 of 1 liter cells resulted in 
roughly 1 mg of protein, which is roughly twice as much as toxin A per liter and most likely due 
to protein length. Furthermore, incubation of HeLa cells with 0.2 nM rTcdB-WT caused 
cytopathic rounding effects within a 2 hour period, proving the rTcdB-WT protein to be active 
(Figure 21).  
For negative control, just as was done for rTcdA-NVN,53  creation of  the enzymatically 
inactive mutant rTcdB-NVN is dependent upon the aspartate to asparagine mutation within the 
active site of the GTD (D286N, D288N). To avoid producing error in the rest of the tcdb gene, 
toxin B GTD was first isolated and PCR amplified from pBMJ_130401 (1946 bp, Figure 22A) 
using primers 1 and 3 from Table 2, followed by direct ligation into TOPO vector 
 
Figure 20: Double digest verification for pBMJ_130401. A: Plasmid map of pBMJ_130401 depicts the tcdb 
gene insert and Xho1/Spe1 digest sites used for determining correct plasmid size. B: DNA isolated from five 







Figure 21: SDS-PAGE gel of purified rTcdB-WT and cytopathic rounding effects of active protein.  Left: 
A clean band in the Ep (elutions pooled) lane shows the expected size of 270 kDa. M: marker. F: flowthrough. 
B: binding buffer wash 1. W: wash buffer wash 2. E1: elution 1. Incubation of healthy HeLa cells (0 hours, 
middle) with 0.2 nM rTcdB-WT for 2 hours resulted in characteristic cytopathic rounding effects (right). 	  
	  
Figure 22: Isolation and site-directed mutagenesis of 
rTcdB-GTD. A: rTcdB-GTD was isolated and amplified 
by PCR from pBMJ_130401 using primers 1 and 3 in 
Table 1. All annealing temperatures between 55°C and 
65°C resulted in the expected amplicon length of 1946 bp. 
B: The GTD was then ligated into TOPO (pBMJ_70401; 
5902 bp). Following transformation into E. coli cells and 
kanamycin selection, the DNA from resultant colonies 
underwent SDM using primers 4 and 5 to create D286N 
and D288N mutations. Plasmid lengths were verified by 
digestion with the BsrG1 and BsaB1 enzymes, to produce 
digest products of 3690, 1641, and 571 bp. M: marker. P: 
digestion reaction products. 	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(pBMJ_70401; Figure 22B left), transformation into electrocompetent E. coli cells, and plating 
on kanamycin antibiotic for selection. Again, select transformant colonies were grown overnight 
to produce ample amounts of DNA that was then isolated and purified. Site-directed mutagenesis 
via PCR with primers 4 and 5 (Table 2) was done to confer D286N and D288N mutations within 
the GTD (pBMJ_70402), and digestion of the PCR product with BsrG1 and BsaB1 restriction 
enzymes resulted in products of 3690, 1641, and 571 bp which confirmed correct plasmid length 
as seen in Figure 22B. Although the smallest digest product of 571 bp ran below the indicated 
500 bp marker, the first two bands and the overall digestion pattern within the gel seemed to be 
correct, therefore the plasmid was sent forth for sequencing and verified via the primers in Table 
4.  In order to create the final rTcdB-NVN B. meg expression plasmid, pBMJ_70402 and 
pBMJ_130401 were digested with BsrG1 and BsaB1 to give the rTcdB-GTD-NVN (1641 bp) 
and pHis1522-tcdb minus the GTD (12817 bp) products, which will need to undergo ligation and 
transformation into B. meg.  
For many reasons, comprehending toxin B functionality in comparison to toxin A, as well 
as determining inhibitory treatment methods that are specified to each toxin is clinically 
important for impeding CDAD as a whole. Not only do some hypervirulent strains express toxin 
B as the sole virulence factor, but also TcdB is more potent in comparison to TcdA and it 
contains a poorly understood pathogenic mechanism that results in necrotic epithelial cell death 
in patients with CDAD. Experimentation pertaining to TcdA has been underway for quite some 
time in the Feig Lab, but previous research utilizing TcdB has been very minimal since C. diff 
toxins are rather costly and until now there wasn’t an obtainable TcdB expression plasmid. 
Although the final ligation and transformation of the rTcdB-NVN plasmid have not been 
completed at this point, the data presented here shows sequence verification for rTcdB-WT 
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(pBMJ_130401; Appendix I) and the components of rTcdB-NVN (Appendix II), where 
expression of rTcdB-WT resulted in ample amounts of active protein that will elicit further 
mechanistic and inhibitory analysis of C. diff toxin B in the future. 
  
Table 3: Sequencing primers for rTcdB-WT.  
 
 




CHAPTER FOUR METHODS 
Clostridium difficile rTcdB-WT cloning. Procedure to isolate, clone, and express C. diff 
toxin B was closely borrowed from Feng, et al.73 Here, C. diff genomic DNA (90556-M6S) was 
purchased from ATTC™ (item number 9689D-5 DR), all primers were synthesized and 
purchased from Sigma, and PCR reactions were done using a Bio-Rad MyCycler Thermo Cycler 
(catalog #19209590). In short, rtcdb was isolated using primers 1 and 2 (Table 2) from C. diff 
genomic DNA as follows: 
 
 
Primers 1 and 2 were equipped with BsrG1 (forward) and Kpn1 (reverse) cut sites and an 
annealing temperature of 53.4 °C was used to move forward. The tcdb amplicon was purified 
using MicroElute Cycle Pure Kit Centrifugation Protocol (OMEGA), eluted in 10 mM Tris-HCl 
pH 8.5, and quantified by A260. pHis1522 (MoBiTec) and the tcdb amplicon then underwent 
double digestion with BsrG1 and Kpn1 restriction enzymes (3 μg DNA, 1X NEB 2.1 Reaction 
Buffer, 30 U BsrG1, and 30 U Kpn1) at 37 °C for 4 hours (0.2 U of calf intestinal alkaline 
phosphatase (CIP) was added to the pHis1522 plasmid digest reaction at the 3 hour mark). Next, 
reactions were mixed with 1X crystal violet loading dye (5% glycerol, 3.3 mM EDTA, 16.6 
μg/mL crystal violet), loaded onto a 0.8% agarose gel containing 1.6 mg/mL crystal violet, 
separated by gel electrophoresis (80 V, 1 hr), and purified using the EZNA Gel Extraction Kit 
(OMEGA). After quantitation at A260, pHis1522 and tcdb insert were ligated together (20 U T4 
tcdb Gene Isolation [Stock] [Final] 1X Vol (µL)
Q5 RXN buffer 5X 1X 4
For Primer "TcdB_F" 10 µM 0.5 µM 1
Rev Primer "TcdB_R" 10 µM 0.5 µM 1
C. diff genomic DNA 20 ng/µL 20 ng 1
dNTP's 10 mM 0.3 mM 0.6
Q5 High Fidelity DNA polymerase 2 U/µL 0.004 U 0.2
Water - - 12.2
Total (µL) - - 20
98°C
72°C 72°C2 min 30 s
30 s







DNA ligase, 1X T4 buffer, 50 ng pHis1522, 37.5 ng tcdb DNA) at RT for 15 min following a 10 
min heat-inactivation period at 65 °C, transforming into top10 E. coli cells by electroporation 
(1.5 μL ligation rxn, 75 μL competent cells), outgrowing in 200 μL standard LB broth (37 °C, 
250 rpm, 30 min), plating on 100 μg/mL ampicillin plates, and incubating at 37 °C overnight. 
Resulting colonies were miniprepped (OMEGA EZNA Plasmid DNA Mini Kit II) and 
sequenced (Wayne State University School of Medicine Applied Genomics Technology Center) 
with primers seen in Table 3. Successful sequencing of rtcdb is shown in Appendix I. 
pHis1522-tcdb (pBMJ_130401) was transformed into B. meg, expressed, and purified as stated 
previously (Chapter 2 Methods). 
Clostridium difficile rTcdB-NVN cloning. Primers 1 and 3 from Table 2 were used to 






The PCR reaction with annealing temperature of 61.1 °C was used to move forward. Ligation of 
tcdb-GTD into pCR-XL-TOPO vector was performed at a 3:1 insert to vector ratio (RT, 30 min) 
before transforming into top 10 E. coli cells and plating on amp LB-agar plates as above. 
Selected colonies were then miniprepped (OMEGA EZNA Plasmid DNA Mini Kit II) and 
resulting DNA (pBMJ_70401) was used with primers 4 and 5 (Table 2) to create D286N/D288N 
mutations as follows: 
95°C
68°C 68°C30 s 30 s
45 s





tcdb-GTD Isolation [Stock] [Final] 1X Vol (µL)
taq RXN buffer 10X 1X 2
For Primer "TcdB_F" 10 µM 0.5 µM 1
Rev Primer "B2R_2" 10 µM 0.5 µM 1
DNA (pBMJ_130401) 2.86 ng/µL 0.5 ng 0.175
MgCl2 15 mM 1.5 mM 2
dNTP's 10 mM 0.5 mM 1
taq polymerase 5 U/µL 0.625 U 0.125
Water - - 12.7








Sequencing of pBMJ_70402 was done using primers in Table 4 and verification can be seen in 
Appendix II.  
HeLa cell cultures. HeLa cell cultures were obtained from the Pflum Lab (Wayne State 
University) and contained to BL2 standard protocols. See Chapter 3 Methods for further 
maintenance procedures and protocols utilizing HeLa cells. Visual cell killing assays were done 




tcdb-NVN SDM PCR [Stock] [Final] 1X Vol (µL)
pfu RXN buffer 10X 1X 2.5
For Primer "rTcdB_NVN_F2" 10 µM 0.25 µM 0.625
Rev Primer "rTcdB_NVN_R2" 10 µM 0.25 µM 0.625
DNA (pBMJ_70401) 10 ng/µL 10 ng 1
dNTP's 10 mM 0.2 mM 0.5
pfu DNA polymerase 5 U/µL 1.25 U 0.25
Water - - 19.5
Total (µL) - - 25
95°C
72°C 72°C2.5 min 1 min
1 min





APPENDIX I: rTcdB-WT Sequence Alignment
FINAL_pHIS1522_TcdB_BMJ.ape (pBMJ_130401; colony 1). Any errors/mismatches were confirmed manually by chromatogram. 
From 16 to 7126 alignment to
3591_B01_TcdB1__B1R_007.seq--  Matches:225; Mismatches:0; Gaps:6906; Unattempted:0
3591_C01_TcdB1__B2F_006.seq--  Matches:882; Mismatches:0; Gaps:6229; Unattempted:0
3591_D01_TcdB1__B2R_005.seq--  Matches:709; Mismatches:0; Gaps:6402; Unattempted:0
3591_F01_TcdB1__B3R_003.seq--  Matches:849; Mismatches:1; Gaps:6261; Unattempted:0
3591_H01_TcdB1__B4R_001.seq--  Matches:766; Mismatches:0; Gaps:6345; Unattempted:0
3591_A02_TcdB1__B5F_008.seq--  Matches:816; Mismatches:0; Gaps:6295; Unattempted:0
3591_B02_TcdB1__B5R_007.seq--  Matches:197; Mismatches:2; Gaps:6912; Unattempted:0
3591_C02_TcdB1__B6F_006.seq--  Matches:444; Mismatches:0; Gaps:6667; Unattempted:0
3591_D02_TcdB1__B6R_005.seq--  Matches:752; Mismatches:0; Gaps:6359; Unattempted:0
3591_E02_TcdB1__B7F_004.seq--  Matches:995; Mismatches:0; Gaps:6116; Unattempted:0
3591_G02_TcdB1__B8F_002.seq--  Matches:579; Mismatches:0; Gaps:6543; Unattempted:0
            *         *         *         *         *         *         *         *         *         *     
     16>~~~~~~~~~~~~~~~~~~~~tgtacaATGAGTTTAGTTAATAGAAAACAGTTAGAAAAAATGGCAAATGTAAGATTTCGTACTCAAGAAGATGAATATGT>95     
    348<ACTTAAATCAAAGGGGGAAATGTACAATGAGTTTAGTTAATAGAAAACAGTTAGAAAAAATGGCAAATGTAAGATTTCGTACTCAAGAAGATGAATATGT<249    
     67>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>67     
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
     96>TGCAATATTGGATGCTTTAGAAGAATATCATAATATGTCAGAGAATACTGTAGTCGAAAAATATTTAAAATTAAAAGATATAAATAGTTTAACAGATATT>195    
    248<TGCAATATTGGATGCTTTAGAAGAATATCATAATATGTCAGAGAATACTGTAGTCGAAAAATATTTAAAATTAAAAGATATAAATAGTTTAACAGATATT<149    
     67>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>67     
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    196>TATATAGATACATATAAAAAATCTGGTAGAAATAAAGCCTTAAAAAAATTTAAGGAATATCTAGTTACAGAAGTATTAGAGCTAAAGAATAATAATTTAA>295    
    148<TATATAGATACATATAAAAAATCTGGTAGAAATAAAGCCTTAAAA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~CTTAAAAAAATTTAAGGAATATCTAGTTACAGAAGTATTAGAGCTAAAGAATAATAATTTAA>129    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    296>CTCCAGTTGAGAAAAATTTACATTTTGTTTGGATTGGAGGTCAAATAAATGACACTGCTATTAATTATATAAATCAATGGAAAGATGTAAATAGTGATTA>395    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    130>CTCCAGTTGAGAAAAATTTACATTTTGTTTGGATTGGAGGTCAAATAAATGACACTGCTATTAATTATATAAATCAATGGAAAGATGTAAATAGTGATTA>229    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    396>TAATGTTAATGTTTTTTATGATAGTAATGCATTTTTGATAAACACATTGAAAAAAACTGTAGTAGAATCAGCAATAAATGATACACTTGAATCATTTAGA>495    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    230>TAATGTTAATGTTTTTTATGATAGTAATGCATTTTTGATAAACACATTGAAAAAAACTGTAGTAGAATCAGCAATAAATGATACACTTGAATCATTTAGA>329    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
44
            *         *         *         *         *         *         *         *         *         *     
    496>GAAAACTTAAATGACCCTAGATTTGACTATAATAAATTCTTCAGAAAACGTATGGAAATAATTTATGATAAACAGAAAAATTTCATAAACTACTATAAAG>595    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    330>GAAAACTTAAATGACCCTAGATTTGACTATAATAAATTCTTCAGAAAACGTATGGAAATAATTTATGATAAACAGAAAAATTTCATAAACTACTATAAAG>429    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    596>CTCAAAGAGAAGAAAATCCTGAACTTATAATTGATGATATTGTAAAGACATATCTTTCAAATGAGTATTCAAAGGAGATAGATGAACTTAATACCTATAT>695    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    430>CTCAAAGAGAAGAAAATCCTGAACTTATAATTGATGATATTGTAAAGACATATCTTTCAAATGAGTATTCAAAGGAGATAGATGAACTTAATACCTATAT>529    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    696>TGAAGAATCCTTAAATAAAATTACACAGAATAGTGGAAATGATGTTAGAAACTTTGAAGAATTTAAAAATGGAGAGTCATTCAACTTATATGAACAAGAG>795    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    530>TGAAGAATCCTTAAATAAAATTACACAGAATAGTGGAAATGATGTTAGAAACTTTGAAGAATTTAAAAATGGAGAGTCATTCAACTTATATGAACAAGAG>629    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    796>TTGGTAGAAAGGTGGAATTTAGCTGCTGCTTCTGACATATTAAGAATATCTGCATTAAAAGAAATTGGTGGTATGTATTTAGATGTTGATATGTTACCAG>895    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    630>TTGGTAGAAAGGTGGAATTTAGCTGCTGCTTCTGACATATTAAGAATATCTGCATTAAAAGAAATTGGTGGTATGTATTTAGATGTTGATATGTTACCAG>729    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    896>GAATACAACCAGACTTATTTGAGTCTATAGAGAAACCTAGTTCAGTAACAGTGGATTTTTGGGAAATGACAAAGTTAGAAGCTATAATGAAATACAAAGA>995    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    730>GAATACAACCAGACTTATTTGAGTCTATAGAGAAACCTAGTTCAGTAACAGTGGATTTTTGGGAAATGACAAAGTTAGAAGCTATAATGAAATACAAAGA>829    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
    996>ATATATACCAGAATATACCTCAGAACATTTTGACATGTTAGACGAAGAAGTTCAAAGTAGTTTTGAATCTGTTCTAGCTTCTAAGTCAGATAAATCAGAA>1095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    830>ATATATACCAGAATATACCTCAGAACATTTTGACATGTTAGACGAAGAAGTTCAAAGTAGTTTTGAATCTGTTCTAGCTTCTAAGTCAGATAAATCAGAA>929    
    813<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<813    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
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            *         *         *         *         *         *         *         *         *         *     
   1096>ATATTCTCATCACTTGGTGATATGGAGGCATCACCACTAGAAGTTAAAATTGCATTTAATAGTAAGGGTATTATAAATCAAGGGCTAATTTCTGTGAAAG>1195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    930>ATATTCTCATCACTTGGTGA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    812<~~~~~~~~~~~~CTTGGTGATATGGAGGCATCACCACTAGAAGTTAAAATTGCATTTAATAGTAAGGGTATTATAAATCAAGGGCTAATTTCTGTGAAAG<725    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1196>ACTCATATTGTAGCAATTTAATAGTAAAACAAATCGAGAATAGATATAAAATATTGAATAATAGTTTAAATCCAGCTATTAGCGAGGATAATGATTTTAA>1295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    724<ACTCATATTGTAGCAATTTAATAGTAAAACAAATCGAGAATAGATATAAAATATTGAATAATAGTTTAAATCCAGCTATTAGCGAGGATAATGATTTTAA<625    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1296>TACTACAACGAATACCTTTATTGATAGTATAATGGCTGAAGCTAATGCAGATAATGGTAGATTTATGATGGAACTAGGAAAGTATTTAAGAGTTGGTTTC>1395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    624<TACTACAACGAATACCTTTATTGATAGTATAATGGCTGAAGCTAATGCAGATAATGGTAGATTTATGATGGAACTAGGAAAGTATTTAAGAGTTGGTTTC<525    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1396>TTCCCAGATGTTAAAACTACTATTAACTTAAGTGGCCCTGAAGCATATGCGGCAGCTTATCAAGATTTATTAATGTTTAAAGAAGGCAGTATGAATATCC>1495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    524<TTCCCAGATGTTAAAACTACTATTAACTTAAGTGGCCCTGAAGCATATGCGGCAGCTTATCAAGATTTATTAATGTTTAAAGAAGGCAGTATGAATATCC<425    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1496>ATTTGATAGAAGCTGATTTAAGAAACTTTGAAATCTCTAAAACTAATATTTCTCAATCAACTGAACAAGAAATGGCTAGCTTATGGTCATTTGACGATGC>1595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    424<ATTTGATAGAAGCTGATTTAAGAAACTTTGAAATCTCTAAAACTAATATTTCTCAATCAACTGAACAAGAAATGGCTAGCTTATGGTCATTTGACGATGC<325    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1596>AAGAGCTAAAGCTCAATTTGAAGAATATAAAAGGAATTATTTTGAAGGTTCTCTTGGTGAAGATGATAATCTTGATTTTTCTCAAAATATAGTAGTTGAC>1695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    324<AAGAGCTAAAGCTCAATTTGAAGAATATAAAAGGAATTATTTTGAAGGTTCTCTTGGTGAAGATGATAATCTTGATTTTTCTCAAAATATAGTAGTTGAC<225    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
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            *         *         *         *         *         *         *         *         *         *     
   1696>AAGGAGTATCTTTTAGAAAAAATATCTTCATTAGCAAGAAGTTCAGAGAGAGGATATATACACTATATTGTTCAGTTACAAGGAGATAAAATTAGTTATG>1795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    224<AAGGAGTATCTTTTAGAAAAAATATCTTCATTAGCAAGAAGTTCAGAGAGAGGATATATACACTATATTGTTCAGTTACAAGGAGATAAAATTAGTTATG<125    
    997<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<997    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1796>AAGCAGCATGTAACTTATTTGCAAAGACTCCTTATGaTAGTGTACTATTTCAGAAAAATATAGAAGATTCAGAAATTGCATATTATTATAATCCTGGAGA>1895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    124<AAGCAGCATGTAACTTATTTG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    996<~~~~~~~~~~~~~CTTATTTGCAAAGACTCCTTATGATAGTGTACTATTTCAGAAAAATATAGAAGATTCAGAAATTGCATATTATTATAATCCTGGAGA<910    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1896>TGGTGAAATACAAGAAATAGACAAGTATAAAATTCCAAGTATAATTTCTGATAGACCTAAGATTAAATTAACATTTATTGGTCATGGTAAAGATGAATTT>1995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    909<TGGTGAAATACAAGAAATAGACAAGTATAAAATTCCAAGTATAATTTCTGATAGACNTAAGATTAAATTAACATTTATTGGTCATGGTAAAGATGAATTT<810    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   1996>AATACTGATATATTTGCAGGTTTTGATGTAGATTCATTATCCACAGAAATAGAAGCAGCAATAGATTTAGCTAAAGAGGATATTTCTCCTAAGTCAATAG>2095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    809<AATACTGATATATTTGCAGGTTTTGATGTAGATTCATTATCCACAGAAATAGAAGCAGCAATAGATTTAGCTAAAGAGGATATTTCTCCTAAGTCAATAG<710    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2096>AAATAAATTTATTAGGATGTAATATGTTTAGCTACTCTATCAACGTAGAGGAGACTTATCCTGGAAAATTATTACTTAAAGTTAAAGATAAAATATCAGA>2195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    709<AAATAAATTTATTAGGATGTAATATGTTTAGCTACTCTATCAACGTAGAGGAGACTTATCCTGGAAAATTATTACTTAAAGTTAAAGATAAAATATCAGA<610    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2196>ATTAATGCCATCTATAAGTCAAGACTCTATTATAGTAAGTGCAAATCAATATGAAGTTAGAATAAATAGTGAAGGAAGAAGAGAATTATTGGATCATTCT>2295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    609<ATTAATGCCATCTATAAGTCAAGACTCTATTATAGTAAGTGCAAATCAATATGAAGTTAGAATAAATAGTGAAGGAAGAAGAGAATTATTGGATCATTCT<510    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
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     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2296>GGTGAATGGATAAATAAAGAAGAAAGTATTATAAAGGATATTTCATCAAAAGAATATATATCATTTAATCCTAAAGAAAATAAAATTACAGTAAAATCTA>2395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    509<GGTGAATGGATAAATAAAGAAGAAAGTATTATAAAGGATATTTCATCAAAAGAATATATATCATTTAATCCTAAAGAAAATAAAATTACAGTAAAATCTA<410    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2396>AAAATTTACCTGAGCTATCTACATTATTACAAGAAATTAGAAATAATTCTAATTCAAGTGATATTGAACTAGAAGAAAAAGTAATGTTAACAGAATGTGA>2495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    409<AAAATTTACCTGAGCTATCTACATTATTACAAGAAATTAGAAATAATTCTAATTCAAGTGATATTGAACTAGAAGAAAAAGTAATGTTAACAGAATGTGA<310    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2496>GATAAATGTTATTTCAAATATAGATACGCAAATTGTTGAGGAAAGGATTGAAGAAGCTAAGAATTTAACTTCTGACTCTATTAATTATATAAAAGATGAA>2595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    309<GATAAATGTTATTTCAAATATAGATACGCAAATTGTTGAGGAAAGGATTGAAGAAGCTAAGAATTTAACTTCTGACTCTATTAATTATATAAAAGATGAA<210    
    972<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<972    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2596>TTTAAACTAATAGAATCTATTTCTGATGCACTATGTGACTTAAAACAACAGAATGAATTAGAAGATTCTCATTTTATATCTTTTGAGGACATATCAGAGA>2695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    209<TTTAAACTAATAGAATCTATTTCTGATGCACTATGTGACTTAAAACAACAGAATGAATTAGAA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    971<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GAATGAATTAGAAGATTCTCATTTTATATCTTTTGAGGACATATCAGAGA<922    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2696>CTGATGAGGGATTTAGTATAAGATTTATTAATAAAGAAACTGGAGAATCTATATTTGTAGAAACTGAAAAAACAATATTCTCTGAATATGCTAATCATAT>2795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    921<CTGATGAGGGATTTAGTATAAGATTTATTAATAAAGAAACTGGAGAATCTATATTTGTAGAAACTGAAAAAACAATATTCTCTGAATATGCTAATCATAT<822    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2796>AACTGAAGAGATTTCTAAGATAAAAGGTACTATATTTGATACTGTAAATGGTAAGTTAGTAAAAAAAGTAAATTTAGATACTACACACGAAGTAAATACT>2895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    821<AACTGAAGAGATTTCTAAGATAAAAGGTACTATATTTGATACTGTAAATGGTAAGTTAGTAAAAAAAGTAAATTTAGATACTACACACGAAGTAAATACT<722    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
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    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2896>TTAAATGCTGCATTTTTTATACAATCATTAATAGAATATAATAGTTCTAAAGAATCTCTTAGTAATTTAAGTGTAGCAATGAAAGTCCAAGTTTACGCTC>2995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    721<TTAAATGCTGCATTTTTTATACAATCATTAATAGAATATAATAGTTCTAAAGAATCTCTTAGTAATTTAAGTGTAGCAATGAAAGTCCAAGTTTACGCTC<622    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   2996>AATTATTTAGTACTGGTTTAAATACTATTACAGATGCAGCCAAAGTTGTTGAATTAGTATCAACTGCATTAGATGAAACTATAGACTTACTTCCTACATT>3095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    621<AATTATTTAGTACTGGTTTAAATACTATTACAGATGCAGCCAAAGTTGTTGAATTAGTATCAACTGCATTAGATGAAACTATAGACTTACTTCCTACATT<522    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3096>ATCTGAAGGATTACCTATAATTGCAACTATTATAGATGGTGTAAGTTTAGGTGCAGCAATCAAAGAGCTAAGTGAAACGAGTGACCCATTATTAAGACAA>3195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    521<ATCTGAAGGATTACCTATAATTGCAACTATTATAGATGGTGTAAGTTTAGGTGCAGCAATCAAAGAGCTAAGTGAAACGAGTGACCCATTATTAAGACAA<422    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3196>GAAATAGAAGCTAAGATAGGTATAATGGCAGTAAATTTAACAACAGCTACAACTGCAATCATTACTTCATCTTTGGGGgTAGCTAGTGGATTTAGTATAC>3295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    421<GAAATAGAAGCTAAGATAGGTATAATGGCAGTAAATTTAACAACAGCTACAACTGCAATCATTACTTCATCTTTGGGGGTAGCTAGTGGATTTAGTATAC<322    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3296>TTTTAGTTCCTTTAGCAGGAATTTCAGCAGGTATACCAAGCTTAGTAAACAATGAACTTGTACTTCGAGATAAGGCAACAAAGGTTGTAGATTATTTTAA>3395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    321<TTTTAGTTCCTTTAGCAGGAATTTCAGCAGGTATACCAAGCTTAGTAAACAATGAACTTGTACTTCGAGATAAGGCAACAAAGGTTGTAGATTATTTTAA<222    
     63>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>63     
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3396>ACATGTTTCATTAGTTGAAACTGAAGGAGTATTTACTTTATTAGATGATAAAATAATGATGCCACAAGATGATTTAGTGATATCAGAAATAGATTTTAAT>3495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    221<ACATGTTTCATTAGTT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
     64>~~~~GTTTCATTAGTTGAAACTGAAGGAGTATTTACTTTATTAGATGATAAAATAATGATGCCACAAGATGATTTAGTGATATCAGAAATAGATTTTAAT>159    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
49
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3496>AATAATTCAATAGTTTTAGGTAAATGTGAAATCTGGAGAATGGAAGGTGGTTCAGGTCATACTGTAACTGATGATATAGATCACTTCTTTTCAGCACCAT>3595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    160>AATAATTCAATAGTTTTAGGTAAATGTGAAATCTGGAGAATGGAAGGTGGTTCAGGTCATACTGTAACTGATGATATAGATCACTTCTTTTCAGCACCAT>259    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3596>CAATAACATATAGAGAGCCACACTTATCTATATATGACGTATTGGAAGTACAAAAAGAAGAACTTGATTTGTCAAAAGATTTAATGGTATTACCTAATGC>3695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    260>CAATAACATATAGAGAGCCACACTTATCTATATATGACGTATTGGAAGTACAAAAAGAAGAACTTGATTTGTCAAAAGATTTAATGGTATTACCTAATGC>359    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3696>TCCAAATAGAGTATTTGCTTGGGAAACAGGATGGACACCAGGTTTAAGAAGCTTAGAAAATGATGGCACAAAACTGTTAGACCGTATAAGAGATAACTAT>3795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    360>TCCAAATAGAGTATTTGCTTGGGAAACAGGATGGACACCAGGTTTAAGAAGCTTAGAAAATGATGGCACAAAACTGTTAGACCGTATAAGAGATAACTAT>459    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3796>GAAGGTGAGTTTTATTGGAGATATTTTGCTTTTATAGCTGATGCTTTAATAACAACATTAAAACCAAGATATGAAGATACTAATATAAGAATAAATTTAG>3895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    460>GAAGGTGAGTTTTATTGGAGATATTTTGCTTTTATAGCTGATGCTTTAATAACAACATTAAAACCAAGATATGAAGATACTAATATAAGAATAAATTTAG>559    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3896>ATAGTAATACTAGAAGTTTTATAGTTCCAATAATAACTACAGAATATATAAGAGAAAAATTATCATATTCTTTCTATGGTTCAGGAGGAACTTATGCATT>3995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    560>ATAGTAATACTAGAAGTTTTATAGTTCCAATAATAACTACAGAATATATAAGAGAAAAATTATCATATTCTTTCTATGGTTCAGGAGGAACTTATGCATT>659    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   3996>GTCTCTTTCTCAATATAATATGGGTATAAATATAGAATTAAGTGAAAGTGATGTTTGGATTATAGATGTTGATAATGTTGTGAGAGATGTAACTATAGAA>4095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    660>GTCTCTTTCTCAATATAATATGGGTATAAATATAGAATTAAGTGAAAGTGATGTTTGGATTATAGATGTTGATAATGTTGTGAGAGATGTAACTATAGAA>759    
50
    
 
            *         *         *         *         *         *         *         *         *         *     
   4096>TCTGATAAAATTAAAAAAGGTGATTTAATAGAAGGTATTTTATCTACACTAAGTATTGAAGAGAATAAAATTATCTTAAATAGCCATGAGATTAATTTTT>4195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    760>TCTGATAAAATTAAAAAAGGTGATTTAATAGAAGGTATTTTATCTACACTAAGTATTGAAGAGAATAAAATTATCTTAAATAGCCATGAGATTAATTTTT>859    
    232<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<232    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4196>CTGGTGAGGTAAATGGAAGTAATGGATTTGTTTCTTTAACATTTTCAATTTTAGAAGGAATAAATGCAATTATAGAAGTTGATTTATTATCTAAATCATA>4295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    860>CTGGTGAGGTAAATGGAAGT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
    231<~~~~~~~~~~AAATGGAAGTAATGGATTTGTTTCTTTAACATTTTCAATTTTAGAAGGAATAAATGCAATTATAGAAGTTGATTTATTATCTAAATCATA<142    
     68>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>68     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4296>TAAATTACTTATTTCTGGCGAATTAAAAATATTGATGTTAAATTCAAATCATATTCAACAGAAAATAGATTATATAGGATTCAATAGCGAATTACAGAAA>4395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
    141<TAAATTACTTATTTCTGGCGAATTAAAAATATTGATGTTAAATTCAAATCATATTCAACAGAAAATAGATTATATAGGANNCAATAGCGAATTACAGAAA<42     
     69>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GAAA>72     
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4396>AATATACCATATAGCTTTGTAGATAGTGAAGGAAAAGAGAATGGTTTTATTAATGGTTCAACAAAAGAAGGTTTATTTGTATCTGAATTACCTGATGTAG>4495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     41<AATATACCA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
     73>AATATACCATATAGCTTTGTAGATAGTGAAGGAAAAGAGAATGGTTTTATTAATGGTTCAACAAAAGAAGGTTTATTTGTATCTGAATTACCTGATGTAG>172    
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4496>TTCTTATAAGTAAGGTTTATATGGATGATAGTAAGCCTTCATTTGGATATTATAGTAATAATTTGAAAGATGTCAAAGTTATAACTAAAGATAATGTTAA>4595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    173>TTCTTATAAGTAAGGTTTATATGGATGATAGTAAGCCTTCATTTGGATATTATAGTAATAATTTGAAAGATGTCAAAGTTATAACTAAAGATAATGTTAA>272    
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4596>TATATTAACAGGTTATTATCTTAAGGATGATATAAAAATCTCTCTTTCTTTGACTCTACAAGATGAAAAAACTATAAAGTTAAATAGTGTGCATTTAGAT>4695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
51
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    273>TATATTAACAGGTTATTATCTTAAGGATGATATAAAAATCTCTCTTTCTTTGACTCTACAAGATGAAAAAACTATAAAGTTAAATAGTGTGCATTTAGAT>372    
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4696>GAAAGTGGAGTAGCTGAGATTTTGAAGTTCATGAATAGAAAAGGTAATACAAATACTTCAGATTCTTTAATGAGCTTTTTAGAAAGTATGAATATAAAAA>4795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    373>GAAAGTGGAGTAGCTGAGATTTTGAAGTTCATGAATAGAAAAGGTAATACAAATACTTCAGATTCTTTAATGAGCTTTTTAGAAAGTATGAATATAAAAA>472    
    848<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<848    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4796>GTATTTTCGTTAATTTCTTACAATCTAATATTAAGTTTATATTAGATGCTAATTTTATAATAAGTGGTACTACTTCTATTGGCCAATTTGAGTTTATTTG>4895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    473>GTATTTTCGTTAATTTCTTACAATCTAATATTAAGTTTAT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    847<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AAGTTTATATTAGATGCTAATTTTATAATAAGTGGTACTACTTCTATTGGCCAATTTGAGTTTATTTG<780    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4896>TGATGAAAATGATAATATACAACCATATTTCATTAAGTTTAATACACTAGAAACTAATTATACTTTATATGTAGGAAATAGACAAAATATGATAGTGGAA>4995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    779<TGATGAAAATGATAATATACAACCATATTTCATTAAGTTTAATACACTAGAAACTAATTATACTTTATATGTAGGAAATAGACAAAATATGATAGTGGAA<680    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   4996>CCAAATTATGATTTAGATGATTCTGGAGATATATCTTCAACTGTTATCAATTTCTCTCAAAAGTATCTTTATGGAATAGACAGTTGTGTTAATAAAGTTG>5095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    679<CCAAATTATGATTTAGATGATTCTGGAGATATATCTTCAACTGTTATCAATTTCTCTCAAAAGTATCTTTATGGAATAGACAGTTGTGTTAATAAAGTTG<580    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5096>TAATTTCACCAAATATTTATACAGATGAAATAAATATAACGCCTGTATATGAAACAAATAATACTTATCCAGAAGTTATTGTATTAGATGCAAATTATAT>5195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    579<TAATTTCACCAAATATTTATACAGATGAAATAAATATAACGCCTGTATATGAAACAAATAATACTTATCCAGAAGTTATTGTATTAGATGCAAATTATAT<480    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5196>AAATGAAAAAATAAATGTTAATATCAATGATCTATCTATACGATATGTATGGAGTAATGATGGTAATGATTTTATTCTTATGTCAACTAGTGAAGAAAAT>5295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
52
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    479<AAATGAAAAAATAAATGTTAATATCAATGATCTATCTATACGATATGTATGGAGTAATGATGGTAATGATTTTATTCTTATGTCAACTAGTGAAGAAAAT<380    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5296>AAGGTGTCACAAGTTAAAATAAGATTCGTTAATGTTTTTAAAGATAAGACTTTGGCAAATAAGCTATCTTTTAACTTTAGTGATAAACAAGATGTACCTG>5395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    379<AAGGTGTCACAAGTTAAAATAAGATTCGTTAATGTTTTTAAAGATAAGACTTTGGCAAATAAGCTATCTTTTAACTTTAGTGATAAACAAGATGTACCTG<280    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5396>TAAGTGAAATAATCTTATCATTTACACCTTCATATTATGAGGATGGATTGATTGGCTATGATTTGGGTCTAGTTTCTTTATATAATGAGAAATTTTATAT>5495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    279<TAAGTGAAATAATCTTATCATTTACACCTTCATATTATGAGGATGGATTGATTGGCTATGATTTGGGTCTAGTTTCTTTATATAATGAGAAATTTTATAT<180    
     24>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>24     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5496>TAATAACTTTGGAATGATGGTATCTGGATTAATATATATTAATGATTCATTATATTATTTTAAACCACCAGTAAATAATTTGATAACTGGATTTGTGACT>5595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
    179<TAATAACTTTGGAATGATGGTATCTGGATTAATATATATTAATGATTCATTATATTATTTTAAACCACCAGTAAATAATTTGAT~~~~~~~~~~~~~~~~<96     
     25>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~CCAGTAAATAATTTGATAACTGGATTTGTGACT>57     
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5596>GTAGGCGATGATAAATACTACTTTAATCCAATTAATGGTGGAGCTGCTTCAATTGGAGAGACAATAATTGATGACAAAAATTATTATTTCAACCAAAGTG>5695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
     58>GTAGGCGATGATAAATACTACTTTAATCCAATTAATGGTGGAGCTGCTTCAATTGGAGAGACAATAATTGATGACAAAAATTATTATTTCAACCAAAGTG>157    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5696>GAGTGTTACAAACAGGTGTATTTAGTACAGAAGATGGATTTAAATATTTTGCCCCAGCTAATACACTTGATGAAAACCTAGAAGGAGAAGCAATTGATTT>5795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    158>GAGTGTTACAAACAGGTGTATTTAGTACAGAAGATGGATTTAAATATTTTGCCCCAGCTAATACACTTGATGAAAACCTAGAAGGAGAAGCAATTGATTT>257    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5796>TACTGGAAAATTAATTATTGACGAAAATATTTATTATTTTGATGATAATTATAGAGGAGCTGTAGAATGGAAAGAATTAGATGGTGAAATGCACTATTTT>5895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
53
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    258>TACTGGAAAATTAATTATTGACGAAAATATTTATTATTTTGATGATAATTATAGAGGAGCTGTAGAATGGAAAGAATTAGATGGTGAAATGCACTATTTT>357    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5896>AGCCCAGAAACAGGTAAAGCTTTTAAAGGTCTAAATCAAATAGGTGATTATAAATACTATTTCAATTCTGATGGAGTTATGCAAAAAGGATTTGTTAGTA>5995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    358>AGCCCAGAAACAGGTAAAGCTTTTAAAGGTCTAAATCAAATAGGTGATTATAAATACTATTTCAATTCTGATGGAGTTATGCAAAAAGGATTTGTTAGTA>457    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   5996>TAAATGATAATAAACACTATTTTGATGATTCTGGTGTTATGAAAGTAGGTTACACTGAAATAGATGGCAAGCATTTCTACTTTGCTGAAAACGGAGAAAT>6095   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    458>TAAATGATAATAAACACTATTTTGATGATTCTGGTGTTATGAAAGTAGGTTACACTGAAATAGATGGCAAGCATTTCTACTTTGCTGAAAACGGAGAAAT>557    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   6096>GCAAATAGGAGTATTTAATACAGAAGATGGATTTAAATATTTTGCTCATCATAATGAAGATTTAGGAAATGAAGAAGGTGAAGAAATCTCATATTCTGGT>6195   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    558>GCAAATAGGAGTATTTAATACAGAAGATGGATTTAAATATTTTGCTCATCATAATGAAGATTTAGGAAATGAAGAAGGTGAAGAAATCTCATATTCTGGT>657    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   6196>ATATTAAATTTCAATAATAAAATTTACTATTTTGATGATTCATTTACAGCTGTAGTTGGATGGAAAGATTTAGAGGATGGTTCAAAGTATTATTTTGATG>6295   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    658>ATATTAAATTTCAATAATAAAATTTACTATTTTGATGATTCATTTACAGCTGTAGTTGGATGGAAAGATTTAGAGGATGGTTCAAAGTATTATTTTGATG>757    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   6296>AAGATACAGCAGAAGCATATATAGGTTTGTCATTAATAAATGATGGTCAATATTATTTTAATGATGATGGAATTATGCAAGTTGGATTTGTCACTATAAA>6395   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    758>AAGATACAGCAGAAGCATATATAGGTTTGTCATTAATAAATGATGGTCAATATTATTTTAATGATGATGGAATTATGCAAGTTGGATTTGTCACTATAAA>857    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   6396>TGATAAAGTCTTCTACTTCTCTGACTCTGGAATTATAGAATCTGGAGTACAAAACATAGATGACAATTATTTCTATATAGATGATAATGGTATAGTTCAA>6495   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
54
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    858>TGATAAAGTCTTCTACTTCTCTGACTCTGGAATTATAGAATCTGGAGTACAAAACATAGATGACAATTATTTCTATATAGATGATAATGGTATAGTTCAA>957    
    341>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>341    
            *         *         *         *         *         *         *         *         *         *     
   6496>ATTGGTGTATTTGATACTTCAGATGGATATAAATATTTTGCACCTGCTAATACTGTAAATGATAATATTTACGGACAAGCAGTTGAATATAGTGGTTTAG>6595   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
    958>ATTGGTGTATTTGATACTTCAGATGGATATAAATATTTTGCACCTGCTAATACTGTAAATGA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    342>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~CTGTAAATGATAATATTTACGGACAAGCAGTTGAATATAGTGGTTTAG>389    
            *         *         *         *         *         *         *         *         *         *     
   6596>TTAGAGTTGGGGAAGATGTATATTATTTTGGAGAAACATATACAATTGAGACTGGATGGATATATGATATGGAAAATGAAAGTGATAAATATTATTTCAA>6695   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    390>TTAGAGTTGGGGAAGATGTATATTATTTTGGAGAAACATATACAATTGAGACTGGATGGATATATGATATGGAAAATGAAAGTGATAAATATTATTTCAA>489    
            *         *         *         *         *         *         *         *         *         *     
   6696>TCCAGAAACTAAAAAAGCATGCAAAGGTATTAATTTAATTGATGATATAAAATATTATTTTGATGAGAAGGGCATAATGAGAACGGGTCTTATATCATTT>6795   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    490>TCCAGAAACTAAAAAAGCATGCAAAGGTATTAATTTAATTGATGATATAAAATATTATTTTGATGAGAAGGGCATAATGAGAACGGGTCTTATATCATTT>589    
            *         *         *         *         *         *         *         *         *         *     
   6796>GAAAATAATAATTATTACTTTAATGAGAATGGTGAAATGCAATTTGGTTATATAAATATAGAAGATAAGATGTTCTATTTTGGTGAAGATGGTGTCATGC>6895   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    590>GAAAATAATAATTATTACTTTAATGAGAATGGTGAAATGCAATTTGGTTATATAAATATAGAAGATAAGATGTTCTATTTTGGTGAAGATGGTGTCATGC>689    
            *         *         *         *         *         *         *         *         *         *     
   6896>AGATTGGAGTATTTAATACACCAGATGGATTTAAATACTTTGCACATCAAAATACTTTGGATGAGAATTTTGAGGGAGAATCAATAAACTATACTGGTTG>6995   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    690>AGATTGGAGTATTTAATACACCAGATGGATTTAAATACTTTGCACATCAAAATACTTTGGATGAGAATTTTGAGGGAGAATCAATAAACTATACTGGTTG>789    
            *         *         *          *         *         *         *         *         *         *    
   6996>GTTAGATTTAGATGAAAAGAGATATTATTTT-ACAGATGAATATATTGCAGCAACTGGTTCAGTTATTATTGATGGTGAGGAGTATTATTTTGATCCTGA>7094   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
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    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
    790>GTTAGATTTAGATGAAAAGAGATATTATTTTTACAGATGAATATATTGCAGCAACTGGTTCAGTTATTATTGATGGTGAGGAGTATTATTTTGATCCTGA>889    
             *         *         *         *
   7095>TACAGCTCAATTAGTGATTAGTGAAGggtacc~~~~~~~~~~>7126   
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    949>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>949    
    104<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<104    
    147<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<147    
    206<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<206    
    879>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>879    
     33<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<33     
    512>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>512    
     96<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<96     
   1019>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>1019   
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APPENDIX II: rTcdB-GTD-NVN Sequence Alignment
rTcdB_GTD_NVN.ape (insert from pBMJ_70402; colony 6) from 295 to 2240
Alignment to
_B03_colony6__M13Reverse_015.seq--  Matches:792; Mismatches:0; Gaps:1154; Unattempted:0
_E02_colony6__B2F_004.seq--  Matches:271; Mismatches:0; Gaps:1675; Unattempted:0
_F02_colony6__B2R_003.seq--  Matches:808; Mismatches:0; Gaps:1138; Unattempted:0
_G02_colony6__B3F_002.seq--  Matches:76; Mismatches:0; Gaps:1870; Unattempted:0
            *         *         *         *         *         *         *         *         *         *    
   295>tgtacaATGAGTTTAGTTAATAGAAAACAGTTAGAAAAAATGGCAAATGTAAGATTTCGTACTCAAGAAGATGAATATGTTGCAATATTGGATGCTTTAG>394    
    54>TGTACAATGAGTTTAGTTAATAGAAAACAGTTAGAAAAAATGGCAAATGTAAGATTTCGTACTCAAGAAGATGAATATGTTGCAATATTGGATGCTTTAG>153    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   395>AAGAATATCATAATATGTCAGAGAATACTGTAGTCGAAAAATATTTAAAATTAAAAGATATAAATAGTTTAACAGATATTTATATAGATACATATAAAAA>494    
   154>AAGAATATCATAATATGTCAGAGAATACTGTAGTCGAAAAATATTTAAAATTAAAAGATATAAATAGTTTAACAGATATTTATATAGATACATATAAAAA>253    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   495>ATCTGGTAGAAATAAAGCCTTAAAAAAATTTAAGGAATATCTAGTTACAGAAGTATTAGAGCTAAAGAATAATAATTTAACTCCAGTTGAGAAAAATTTA>594    
   254>ATCTGGTAGAAATAAAGCCTTAAAAAAATTTAAGGAATATCTAGTTACAGAAGTATTAGAGCTAAAGAATAATAATTTAACTCCAGTTGAGAAAAATTTA>353    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   595>CATTTTGTTTGGATTGGAGGTCAAATAAATGACACTGCTATTAATTATATAAATCAATGGAAAGATGTAAATAGTGATTATAATGTTAATGTTTTTTATG>694    
   354>CATTTTGTTTGGATTGGAGGTCAAATAAATGACACTGCTATTAATTATATAAATCAATGGAAAGATGTAAATAGTGATTATAATGTTAATGTTTTTTATG>453    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   695>ATAGTAATGCATTTTTGATAAACACATTGAAAAAAACTGTAGTAGAATCAGCAATAAATGATACACTTGAATCATTTAGAGAAAACTTAAATGACCCTAG>794    
   454>ATAGTAATGCATTTTTGATAAACACATTGAAAAAAACTGTAGTAGAATCAGCAATAAATGATACACTTGAATCATTTAGAGAAAACTTAAATGACCCTAG>553    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   795>ATTTGACTATAATAAATTCTTCAGAAAACGTATGGAAATAATTTATGATAAACAGAAAAATTTCATAAACTACTATAAAGCTCAAAGAGAAGAAAATCCT>894    
   554>ATTTGACTATAATAAATTCTTCAGAAAACGTATGGAAATAATTTATGATAAACAGAAAAATTTCATAAACTACTATAAAGCTCAAAGAGAAGAAAATCCT>653    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   895>GAACTTATAATTGATGATATTGTAAAGACATATCTTTCAAATGAGTATTCAAAGGAGATAGATGAACTTAATACCTATATTGAAGAATCCTTAAATAAAA>994    
   654>GAACTTATAATTGATGATATTGTAAAGACATATCTTTCAAATGAGTATTCAAAGGAGATAGATGAACTTAATACCTATATTGAAGAATCCTTAAATAAAA>753    
   647>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>647    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
   995>TTACACAGAATAGTGGAAATGATGTTAGAAACTTTGAAGAATTTAAAAATGGAGAGTCATTCAACTTATATGAACAAGAGTTGGTAGAAAGGTGGAATTT>1094   
   754>TTACACAGAATAGTGGAAATGATGTTAGAAACTTTGAAGAATTTAAAAATGGAGAGTCATTCAACTTATATGAACAAGAGTTGGTAGAAAGG~~~~~~~~>845    
   648>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GTGGAATTT>656    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
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            *         *         *         *         *         *         *         *         *         *    
  1095>AGCTGCTGCTTCTGACATATTAAGAATATCTGCATTAAAAGAAATTGGTGGTATGTATTTAaATGTTaATATGTTACCAGGAATACAACCAGACTTATTT>1194   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   657>AGCTGCTGCTTCTGACATATTAAGAATATCTGCATTAAAAGAAATTGGTGGTATGTATTTAAATGTTAATATGTTACCAGGAATACAACCAGACTTATTT>756    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1195>GAGTCTATAGAGAAACCTAGTTCAGTAACAGTGGATTTTTGGGAAATGACAAAGTTAGAAGCTATAATGAAATACAAAGAATATATACCAGAATATACCT>1294   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   757>GAGTCTATAGAGAAACCTAGTTCAGTAACAGTGGATTTTTGGGAAATGACAAAGTTAGAAGCTATAATGAAATACAAAGAATATATACCAGAATATACCT>856    
   842<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<842    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1295>CAGAACATTTTGACATGTTAGACGAAGAAGTTCAAAGTAGTTTTGAATCTGTTCTAGCTTCTAAGTCAGATAAATCAGAAATATTCTCATCACTTGGTGA>1394   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   857>CAGAACATTTTGACATGTTAGACGAAGAAGTTCAAAGTAGTTTTGAATCTGTTCTAGCTTCT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   841<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AAGTCAGATAAATCAGAAATATTCTCATCACTTGGTGA<804    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1395>TATGGAGGCATCACCACTAGAAGTTAAAATTGCATTTAATAGTAAGGGTATTATAAATCAAGGGCTAATTTCTGTGAAAGACTCATATTGTAGCAATTTA>1494   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   803<TATGGAGGCATCACCACTAGAAGTTAAAATTGCATTTAATAGTAAGGGTATTATAAATCAAGGGCTAATTTCTGTGAAAGACTCATATTGTAGCAATTTA<704    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1495>ATAGTAAAACAAATCGAGAATAGATATAAAATATTGAATAATAGTTTAAATCCAGCTATTAGCGAGGATAATGATTTTAATACTACAACGAATACCTTTA>1594   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   703<ATAGTAAAACAAATCGAGAATAGATATAAAATATTGAATAATAGTTTAAATCCAGCTATTAGCGAGGATAATGATTTTAATACTACAACGAATACCTTTA<604    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1595>TTGATAGTATAATGGCTGAAGCTAATGCAGATAATGGTAGATTTATGATGGAACTAGGAAAGTATTTAAGAGTTGGTTTCTTCCCAGATGTTAAAACTAC>1694   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   603<TTGATAGTATAATGGCTGAAGCTAATGCAGATAATGGTAGATTTATGATGGAACTAGGAAAGTATTTAAGAGTTGGTTTCTTCCCAGATGTTAAAACTAC<504    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1695>TATTAACTTAAGTGGCCCTGAAGCATATGCGGCAGCTTATCAAGATTTATTAATGTTTAAAGAAGGCAGTATGAATATCCATTTGATAGAAGCTGATTTA>1794   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   503<TATTAACTTAAGTGGCCCTGAAGCATATGCGGCAGCTTATCAAGATTTATTAATGTTTAAAGAAGGCAGTATGAATATCCATTTGATAGAAGCTGATTTA<404    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1795>AGAAACTTTGAAATCTCTAAAACTAATATTTCTCAATCAACTGAACAAGAAATGGCTAGCTTATGGTCATTTGACGATGCAAGAGCTAAAGCTCAATTTG>1894   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   403<AGAAACTTTGAAATCTCTAAAACTAATATTTCTCAATCAACTGAACAAGAAATGGCTAGCTTATGGTCATTTGACGATGCAAGAGCTAAAGCTCAATTTG<304    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  1895>AAGAATATAAAAGGAATTATTTTGAAGGTTCTCTTGGTGAAGATGATAATCTTGATTTTTCTCAAAATATAGTAGTTGACAAGGAGTATCTTTTAGAAAA>1994   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   303<AAGAATATAAAAGGAATTATTTTGAAGGTTCTCTTGGTGAAGATGATAATCTTGATTTTTCTCAAAATATAGTAGTTGACAAGGAGTATCTTTTAGAAAA<204    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
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            *         *         *         *         *         *         *         *         *         *    
  1995>AATATCTTCATTAGCAAGAAGTTCAGAGAGAGGATATATACACTATATTGTTCAGTTACAAGGAGATAAAATTAGTTATGAAGCAGCATGTAACTTATTT>2094   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   203<AATATCTTCATTAGCAAGAAGTTCAGAGAGAGGATATATACACTATATTGTTCAGTTACAAGGAGATAAAATTAGTTATGAAGCAGCATGTAACTTATTT<104    
    72>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>72     
            *         *         *         *         *         *         *         *         *         *    
  2095>GCAAAGACTCCTTATGaTAGTGTACTATTTCAGAAAAATATAGAAGATTCAGAAATTGCATATTATTATAATCCTGGAGATGGTGAAATACAAGAAATAG>2194   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
   103<GCAAAGACTCCTTATGATAGTGTACTATTTCAGAAAAATATAGAAGATTCAGAAATTGCATATTATTATA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<34     
    73>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ATCCTGGAGATGGTGAAATACAAGAAATAG>102    
            *         *         *         *         *
  2195>ACAAGTATAAAATTCCAAGTATAATTTCTGATAGACCTAAGATTAA>2240   
   845>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>845    
   918>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~>918    
    34<~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<34     
   103>ACAAGTATAAAATTCCAAGTATAATTTCTGATAGACCTAAGATTAA>148    
59
 60 
APPENDIX III: pBMJ Plasmid Constructs 





pBMJ_130401 pHis1522a tcdb-WTb 14458 1 & 2 BsrG1/Kpn1 Amp (E. coli); Tet (B. meg)
pBMJ_70401 pCR-XL-TOPO tcdb-GTD 5902 1 & 3 BsrG1/BsaB1 Kan
pBMJ_70402 pBMJ_70401 (pCR-XL-TOPO) tcdb-GTD-NVN 5902 4 & 5 (SDM) - Kan
NOTE: Grey indicates protein expression plasmids.  ai.e. pANK_80403: created by modifying pWH1520.50      
bIsolated from C. difficile genomic DNA (ATTC 9689D-5 DR).  cSee Table 2.
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 Clostridium difficile (C. diff) is an anaerobic, spore-forming pathogen responsible 
for hospital-acquired C. diff-associated diseases (CDAD) that are extremely common 
following patient treatment with broad-spectrum antibiotics. Symptoms of CDAD range 
from excessive diarrhea, colonic inflammation, pseudomembranous colitis, and in 
extreme cases, death. Although enterotoxins A and B (TcdA and TcdB, respectively) are 
the main virulence factors involved and antibiotic-resistant strains are continually 
emerging today, antibiotic treatment remains the most common method against CDAD. 
The work presented here details a potential anti-toxin therapeutic utilizing an epoxide-
containing peptide (NH2-HQSPGepoxyHHGGGC-CONH2) that covalently crosslinks the 
enzymatic domain of TcdA and has shown to inhibit glucosyltransferase activity in a 
concentration and time-dependent manner. While further analysis is still needed, anti-
toxin, peptide-based agents as such show promising potential for an advanced remedy 
against CDAD.   
 
 
 
